 
 
 
 
 
 
 
 
 
Curriculum Vitae  
 
(May 17, 2017 ) 
 
 
 
 
Shigeto Yamawaki, MD, PhD  
 
Distinguished Professor , Psychiatrist  
Graduate School  of Biomedical and Health Sciences  
Hiroshima University  
1-2-3 Kasumi, Minami -ku, Hiroshima 734 -8551, JAPAN  
 
Phone: +81 -82-257-5205  
Fax: +81 -82-257-5209  
E-mail: yamawaki@hiroshima -u.ac.jp  
 
 
 
 
 
 
 
 
 
 
 
 
 
PERSONAL INFORMATION............................................................................ ...........................  2    
EDUCATION................................................ .................................................... ...........................  2   
ACADEMIC APPOINTMENTS AND EMPLOYMENT...................................... ...........................  2   
PROFESSIONAL SOCIETIES............................................ ............................. ...........................  3 
EDITORIAL BOARDS...................................................................................... ...........................  4   
PROFESSIONAL ACTIVITIES........................................ ................................. ...........................  4   
HONORS AND AWARDS................................................................................ ...........................  4   
PAST AND CURRENT RESEARCH GRANT SUPPORT....................... ......... ...........................  4  
BIBLIOGRAPHY............................................................................................... ...........................  6  
ORIGINAL ARTICLES............................................................. ....................... ...........................  6  
REVIEW ARTICLES...................................................................................... ...........................  18 
BOOK CHAPTERS......................................................... .............................. .............................  19 
  2 
PERSONAL INFORMATION  
 
NAME:  Shigeto Yamawaki  
DATE OF BIRTH:  January 15, 1954  
PLACE OF BIRTH:  Hiroshima Japan  
CITIZENSHIP:  Japanese  
MARITAL STATUS:  Married, Yukiko Yamawaki  
CHILDREN:  Yosuke Ya mawaki, September 11, 1979  
 Kanako Yamawaki, November 14, 1982  
HOME ADRESS  1-9-41 Ushita -asahi, Higashi -ku, 732 -0067, Hiroshima, JAPAN  
OFFICE ADRESS  1-2-3 Kasumi, Minami -ku, 734 -8551, Hiroshima, JAPAN  
 
 
EDUCATION  
 
1969 - 1972  Hiroshima Motomachi High Schoo l 
1972 - 1973  School of Technology, Hiroshima University  
1973 - 1979  School of Medicine, Hiroshima University  
1979 - 1980  Internship, Department of Neurology and Psychiatry, Hiroshima University Hospital  
 
 
PROFESSIONAL CERTIFICATION  
 
1979  Diplomate, Nation al Board of Medical Examiners of Japan (License #: 246357)  
1985  Degree of Ph.D. (Medicine), Hiroshima University  
1987  Diplomate, Designated Psychiatrist by Mental Health Act of Japan (License #: 5263)  
2000  Diplomate in Geriatric Psychiatry, Japanese Society of Geriatric Psychiatry (JSGP)  
2001  Diplomate in Consultation -Liaison Psychiatry, Japanese Society of General Hospital  
 Psychiatry (JSGHP)  
2005  Diplomate in Psychiatry  and Neurology , Japanese Society of Psychiatry and  
Neurology (JSPN) 
 
 
ACADEMIC APPOINTMENTS AND EMPLOYMENT  
 
1981 – 1983  Staff Psychiatrist, Kure National Hospital  
1981 – 1989  Instructor, School of Rehabilitation, Kure National Hospital  
1982 – 1983  Research Fellow in Psychiatry and Behavioral Neurosciences, School of Medicine, 
University of Washington  USA 
1983 – 1990  Director, Laboratory of Psychiatry and Neuroscience, Division of Clinical Research, 
Kure National Hospita l 
1983 – 1990  Adjunct Assistant Professor, Department of Psychiatry,  School of Medicine, 
Hiroshima University  
1990 – 2001  Professor and Chairman, Department of Psychiatry and Neurosciences, School of 
Medicine, Hiroshima University  
1991  Adjunct Assistant Professor, Department of Psychiatry, School of Medicine, Gunma 
Univer sity 
1992  Adjunct Professor, Department of Neurology and Psychiatry,  School of Medicine, 
Okayama University  
1994 – 2002  Adjunct Professor, Department of Psychiatry, Yamanashi Medical University  
1995 – present  Adjunct Professor, Department of Psychiatry, Sa pporo Medical University  
1997 – present  Adjunct Professor, Department of Psychiatry, Shimane Medical University  
1997 – 1999  Adjunct Professor, Department of Psyc hiatry, Shiga Medical Universit y 
2000 – 2004   Adjunct Professor, Department of Psychiatry, Scho ol of Medicine, Yamaguchi 
University  
2000 – 2006  Adjunct Professor, Department of Psychiatry, School of Medicine,  
  Mie University  
2001 – 2017  Professor and Chairman, Department of Psychi atry and Neurosciences,  Institute   
 of Biomedical and Health Sciences , Hiroshima University  
2003 - 2004  Vice-Director, Hiroshima University  Hospital  
2012 - 2014  Board of Director, National Center for Neurology and Psychiatry  
2012 - present     Board of Director, Hiroshima University  
2015 - present       Member and Chair, Br ain and Mind Committee, Science Council of Japan   3 
2016 – 2019   Adjunct Professor, Department of Psychiatry and Psychotherapy,  
 Medical University of Vienna  
2017 – present  Distinguished Professor, Graduate School of Biomedical & Health Sciences, Hiroshima 
University  
 
 
PROFESSIONAL SOCIETIES  
 
Collegium Internationale Neuro -Psychopharmacologicum (CINP)  
- Fellow, 1988 -present  
- Council or, 2002 -2006 
- Secretary, 200 6-2008 
- Chairman, Asia n Regional Meeting  in Hiroshima , 2001  
- Chairman, Asian Regional Committee, 2006 -present 
- President -Elect, 2012 -2014  
- President, 2014 -2016  
- Past-President, 2016 -2018  
International College of Geriatric Psychoneuropharmacology (ICGP)  
- Founding Member, 2000        
- Member, 2000 -present  
- Councilor, 2000 -present  
- President , 2006 -2008  
International Col lege of Asian College of Neuropsychopharmacology  (AsCNP ) 
- Founding Member, 200 8  
- Member, 2008 -present         
- Founding President, 2008 -2010  
- Chairman, 1st Biannual Meeting in Kyoto  
International Society for Bipolar Disorders (ISBD)  
- Member, 1999 -present  
- Counci lor, 2002 -2004  
World Federation of Societies of Biological Psychiatry (WFSBP)  
- Member, 1990 -present  
- Scientific Committee Member, 2000  
European College of Neuropsychopharmacology (ECNP)  
- Foreign Corresponding Member, 1998 -present  
American  College of Neuropsyc hopharmacology ( ACNP)  
- Foreign Corresponding Member, 2004 -2010  
- Fellow , 2011 -present  
American Psychiatric Association (APA)  
- International Member, 1995 -present  
Neuroleptic Malignant Syndrome Information Service (NMSIS)  
- Member,  1997 -present  
- Professional Advi sory Council, 1997 -present 
International Psycho -Oncology Society (IPOS)  
- Member, 1990 -present  
Japanese Society of Neuropsychopharmacology (JSNP)  
- Member, 1980 -present  
- Councilor , 1994 -1998, 2000 -2003, 2005 -2008  
- President, 2010 -2012  
- Chairman, 38th Annual Meeti ng, 2008 in Tokyo  
Japanese Society of Clinical Neuropsychopharmacology (JSCNP)  
- Member, 1996 -present  
- Councilor, 1996 -present  
- Chairman, 11th Annual Meeting, 2001  in Hiroshima  
Japanese Society of Biological Psychiatry (JSBP)  
- Member, 1986 -present  
- Councilor, 19 99-2001, 2003 – 2006 , 2009 - present  
Japanese Society of Neurochemistry (JSN)  
- Member, 1984 -present  
- Councilor, 1999 -2001  
Japanese Society of Psychiatry and Neurology (JSPN)  
- Member, 1980 -present  
- Trustee, 1990 -present   4 
- Chairman, 106th Annual Meeting, 2010 in H iroshima  
Japanese Society of Geriatric Psychiatry (JSGP)  
- Member, 2000 -present  
- Trustee, 2000 -present  
Japanese Society of General Hospital Psychiatry (JSGHP)  
- Member, 1986 -present  
- Councilor, 1990 -present 
- Chairman, 8th Annual Meeting, 1994  in Hiroshima  
Japanes e Society of Psycho -oncology (JPOS)  
- Member, 1990 -present  
- Councilor, 1990 -present  
- President, 2001 -2005  
- Chairman, 12th Annual Meeting, 1999  in Hiroshima  
Japanese Society of Palliative Medicine (JSPM)  
- Member, 1995 -present  
- Councilor, 1 995-2008  
- Chairman, 4th Annual Meeting, 1999  in Hiroshima  
Japanese Society of Psychosomatic Medicine (JAPM)  
- Member, 1992 -present  
- Trustee, 1992 -present  
 
 
EDITORIAL BOARDS  
 
Board  Member , Journal of Psychiatry and Clinical Neurosciences , 1996 -present  
Board  Member , International Journa l of Neuropsychopharmacology , 1997 -2006  
Board  Member , European Neuropsychopharmacology , 1999 -2009  
Associate Editor , International Journal of Psychiatry in Clinical Practice , 1999 -present  
Board  Member , Bipolar Disorders , 2000 -2006  
Board  Member , Biological P sychiatry , 2001 -2005  
Board  Member , Life Sciences , 2001 -present  
Associate Editor  (Asia) , CNS Spectrum , 2000 -present  
Board  Member , Neuropsychiatric Disease and Treatment , 200 3-present  
Board  Member , World Journal of Biological Psychiatry , 2009 -present  
 
PROFES SIONAL ACTIVITIES  
 
Member , National Board Committee of Medical Examiners in Japan , 1997 -2001  
Member , Review  Board , Neuroscience Promotion Project, Longevity and Aging Foundation , 1998 -2000  
Member , Committee of Psychotropic Drugs, Food and Drug Administrati on of Japan , 2001 -present  
Councilor , Medical and Pharmaceutical Frontier Foundation , 2003 -present  
Member , Review  Committee , RIKEN Brain Science Institute (Chair, Steve Hyman),  2003  
Member , Review Committee , Mitsubishi Chemical Life Science Institute , 2003 -2005  
Associate Member , Science Council of Japan, 2006 -present  
 
HONORS AND AWARDS  
 
1983   Kinugasa Best Doctor Award, Kure National Hospital  
1987   Kojinkai Best Investigator Award, Alumni Association of School of Medicine, Hiroshima 
University  
2000   Best Pos ter Award, XXII Congress of Collegiucum of Internationale 
Neuropsychopharmacologicum (CINP) at Brussels  
2002   Distinguished Investigator Award, Japanese Society for Clinical Nuropsychopharmacology 
(JSCNP) at Niigata  
2005   President Award, Advance Telecommu nications Research Institute International  
2005   Best Publication Award for Nature Neuroscience  7: 887 -893(2004 ), Japanese Neural 
Network Society  
2012  Science Technology Award by Minister of Education, Culture, Sports, Science and 
Technology, Japan  
 
 
 
  5 
 
PAST AND CURRENT RESEARCH GRANT SUPPORT    (Exclude Labor Cost, 1$ ≒¥ 90) 
 
Investigator , Health Science Research Grants for Nervous and Mental Disorders, Ministry of Health and 
Welfare, "Studies on Neurochemical Mechanism of the Pathgenesis in Depression". 198 3-1984, 
¥ 2,000,000.  
Investigator , Health Science Research Grants for Nervous and Mental Disorders, Ministry of Health and 
Welfare,"Studies on Serotonergic Mechanism of Manic -Depressive Illness". 1985 -1987, ¥ 2,500,000.  
Principal  Investigator , Research Gra nts for Collaboration of National Hospitals, Ministry of Health and 
Welfare, "Studies on the Pathophysiology and Treatment of Neuroleptic Malignant Syndrome". 1986 -1988, 
¥ 5,000,000.  
Investigator , Health Science Research Grants for Nervous and Mental Disor ders, Ministry of Health and 
Welfare, "Studies on Serotonin 2A Receptors and their Signal Transduction in the Pathophysiology of 
Affective Disorders". 1987 -1990, ¥ 5,400,000.  
Investigator , Grand -in-aid for Cancer Reaserch, Ministry of Health and Welfare, " Psychiatric Issues of 
Terminal State of Cancer Patients". 1989 -1994, ¥ 4,000,000.  
Investigator , Health Science Research Grants for Nervous and Mental Disorders, Ministry of Health and 
Welfare, "Effect of Lithium on Intracellular Calcium Mobilization System ". 1993 -1995, ¥ 3,500,000.  
Investigator , Health Science Research Grants for HIV, Human Science Foundation, "Studies on the Onset 
Mecanism of Neuropsychiatric Disorders in AIDS and its Treatment". 1993 -1995, ¥ 14,500,000.  
Investigator , Health Science Resear ch Grants for Health Promotion and Biodefence Mechanism, Human 
Science Foundation, "Studies on the Mecanism of Stress -induced Neuropsychiatric Disorders and the 
Development of its Treatment". 1993 -1997, ¥ 13,500,000.  
Investigator , Health Science Research G rants for Mental Health, Ministry of Health and Welfare, "Studies on 
Medical Network of Treatment System of Physical Complication in Psychiatric Patients". 1994 -1995, 
¥ 10,000,000.  
Investigator , Research Grants for New Strategy of Cancer Treatment, Ministr y of Health and Welfare, 
"Studies on Palliative Medicine of Cancer Patients". 1994 -1996, ¥ 5,700,000.  
Principal  Investigator , Grant -in-aid for General Scientific Research, Ministry of Education, Sciences and 
Culture, "Psycho -neuro -immunological Studies on the Pathogenesis of Mood Disorders". 1994 -1996, 
¥ 12,100,000.  
Principal  Investigator , Research Grants for New Strategy of Cancer Treatment, Ministry of Health and 
Welfare, "Studies on the Supportive Care for the QOL Improvement of Cancer Patients". 1997 -2000, 
¥ 24,400,000.  
Principal  Investigator , Grants -in-aid for Cancer Research, Ministry of Health and Welfare, "Studies on the 
Mechanism of Psychiatric Symptoms in Cancer Patients and Their Treatment". 2000 -2002, ¥ 25,800,000.  
Investigator , Research Grants f or Longevity Sciences, Ministry of Health and Welfare, 
"Psycho -neuro -immunological Studies on Biological Marker of Aging of Mental Function". 1997 -2002, 
¥ 12,500,000.  
Principal  Investigator , Grant -in-aid for Promising Scientific Research, Ministry of Educa tion, Sciences and 
Culture, " Psycho -neuro -immunological Studies on  Psychiatric Intervention to Cancer Patients ". 1994 -1995, 
¥ 1,900,000.  
Investigator , Health Science Research Grants for Brain Sciences, Ministry of Health and Welfare, "Molecular 
Biologica l Studies on the Mechanism of Pathogenesis and Recovery of Major Depression ". 1997 -1999, 
¥ 21,500,000.  
Principal  Investigator , Grant -in-aid for General Scientific Research, Ministry of Education, Sciences and 
Culture, "International Collaboration Program of Psycho -immunological Studies on Cancer Patients". 1999, 
¥ 3,300,000.  
Principal  Investigator , Grant -in-aid for General Scientific Research, Ministry of Education, Sciences and 
Culture, "Studies of Emotional Neuroplasticity in Pathophysiology of Mood Diso rders". 2002 -2004, 
¥ 12,900,000.  
Investigator , Core Research for Evolutional Science and Technology (CREST) pf Japan Science and 
Technology(JST) "Studies on Mechanism of Behavioral Meta -Learning and Emotional Communication". 
1999 -2003, ¥ 68,500,000.  
Princi pal Investigator , Health Science Research Grants for Brain Sciences, Ministry of Health and Welfare, 
"Elucidation of Molecular Basis of Maladaptive Change in the Brain and Development of its Prevention". 
2000 -2002, ¥ 78,500,000.  
Principal  Investigator , Gra nts-in-aid for Cancer Research, Ministry of Health and Welfare, "Studies on the 
Mechanism of Psychiatric Symptoms in Cancer Patients and Their Treatment". 2003 -2004, ¥ 25,000,000.  
Principal  Investigator , Health Science Research Grants for Nervous and Menta l Disorders, Ministry of Health 
and Welfare,"Studies on Molecular Pathophysiology of Psychiatric Disorders and Their Treatment and 
Prevention". 2003 -2005, ¥ 60,000,000.   6 
Principal  Investigator , Health Science Research Grants for Mental Health Sciences, Mini stry of Health and 
Welfare,"Studies on Pathomechanism of Stress -related Mental Disorders and Development of Their 
Prevention". 2003 -2005, ¥ 75,000,000.  
Principal  Investigator , Grant -in-aid for General Scientific Research, Ministry of Education, Sciences an d 
Culture, "Studies on Pathophysiology and Treatment of Vascular Depression ". 200 4-2006, ¥ 16,900,000.  
Principal  Investigator , Grant -in-aid for General Scientific Research, Ministry of Education, Sciences and 
Culture, " Neuroimaging Study on Role of Seroton in in Impulsivity ". 200 4-2006, ¥ 12,000,000.  
Principal  Investigator , Health Science Research Grants for Mental Health Sciences, Ministry of Health and 
Welfare," Bio-Psycho -Social Studies on Prediction of Treatment -resistant Depression ". 200 6-2008, 
¥ 80,000, 000. 
Principal  Investigator , Grant -in-aid for General Scientific Research, Ministry of Education, Sciences and 
Culture, " Neuroimaging Study on Emotion -Cognition  Regulation  System ". 200 7-2010, ¥ 14,400,000.  
Principal  Investigator , Grant -in-aid for General S cientific Research, Ministry of Education, Sciences and 
Culture, " Role of Chromatin Remodeling in the Pathophysiology and Treatment of Major Depression ". 
2007-2010, ¥ 14,400,000.  
Investigator , Core Research for Evolutional Science and Technology (CREST) of Japan Science and 
Technology(JST) " Development of New Diagnosis and Therapy of Treatment -resistant Depression focused 
on BDNF ". 2008 -2013, ¥ 76,280,000  
Principal  Investigator , Strategic Research Program for Brain Sciences , Ministry of Education, Sciences and 
Culture, " Innovative Development of Diagnosis  and Treatment for Depression based on Its Neurocircuitry 
and Molecular Pathophysiology ". 2011-2016, ¥ 482,50 0,000.  
Research Reader , Center of Innovation Science and Technology based  Radical Innovation and 
Entrepreneruship  Program  (COI STREAM) , Ministry of Education, Culture, Science and Technology,  “Center 
of KANSEI Innovation Nurturing Mental Wealth”   2013-2016, ¥ 950,000,000. 
Principal  Investigator , Strategic Research Program for Brain Sciences  (SRPBS) , Japan Agency for Medical 
Research and Development (AMED)  "Innovative Development of D iagnosis  and Treatment for Depres sion 
by Neuroscience -based  Stratification and Modification of Neural Circuitry ". 2016-2020, ¥ 400,0 00,000  
(estimated) . 
 
 
 
BIBLIOGRAPHY  
 
- Original Articles  
 
<Japanese Journals>    401 
 
<English Journals>  
 
1. Yamawaki,S. : Effect of toluene inhalation on locomotor activity and brain catecholamine levels in rats. 
Japanese Journal of Psychopharmacolog y 2: 57 -59, 1982.  
2. Yamawaki,S.,Segawa,T. and Sarai, K. : Effects of acute and chronic toluene inhalation on behavior and 
[3H] serotonin binding in rat. Life Sciences  30: 1997 -2002, 1982.  
3. Yamawaki,S. : Clinical investigations on 10 cases of organic solvent abuse. Japanese Journal of Alcohol 
& Drug Dependence  17: 123 -128, 1982 . 
4. Yamawaki,S. and Horita,A. : Dopaminergic and serotonergic mechanisms of thermoregulation: 
Mediation of thermal effects of apomorphine and dopamine. The Journal of Pharmacology ad 
Experimental Therapeutics  227: 383 -388, 1983.  
5. Horita,A.,C arino,M.A. and Yamawaki,S. : Morphine antagonized pentobarbital -induced anesthesia. 
Neuropharmacology  22: 1183 -186, 1983.  
6. Hotta,I.,Yamawaki,S. and Segawa,T. : Effect of lithium on serotonin receptor -agonists cyclase system in 
rat hippocampus. Folia Psychia trica et Neurologica Japonica  38: 395 -397, 1984.  
7. Yamawaki,S., Lai,H. and Horita,A. : Effect of dopaminergic and serotonergic drugs on ethanol -induced 
hypothermia. Life Sciences  34: 467 -474, 1984.  
8. Yamawaki,S.,Yanagawa,K.,Hotta,I. and Sarai,K. : Effect of li thium chloride on thermoregualatory 
mechanism. Folia Psychiatrica et Neurologica Japanica  38: 396 -397, 1984 . 
9. Horita,A.,Carino,M.A. and Yamawaki,S. : Analeptic effect of opiate receptor agonists in rabbits. 
Neuroscience Letters  55: 61 -64, 1985.  
10. Yamawaki,S., Nagao,M.,Yanagawa,K.,Uchitomi,Y. and Hotta,I. : Lithi um changed amine precursor 
amino acids, but not neurotransmitter candidate amino acids in rats. Folia Psychiatrica et Neurologica 
Japonica  39: 597 -598, 1985.  
11. Hotta,I.,Yamawaki,S.,Yanagawa,K. and Segawa,T . : Effect of lithium on serotonin receptors in rat brain:  7 
a behavioral study. Folia Psychiatrica et Neurologica Japonica  39: 593 -594, 1985.  
12. Hotta,I. and Yamawaki,S. : Lithium decreases 5 -HT1 receptors but incereses 5 -HT sensitive adenylate 
cyclase activit y in rat hippocampus. Biological Psychiatry  21: 138 -139, 1986.  
13. Yamawaki,S.,Yanagawa,K.,Morio,M. and Mori,K. : Possible central effect of dantrolene sodium in 
neuroleptic maglignant symdrome. Journal of Clinical Psychopharmacology  6: 378 -379, 1986.  
14. Hotta,I. ,Yamawaki,S. and Segawa,T. : Long -tern lithium treatment causes serotonin receptor 
down -regulation via serotonergic presynaptses in rat brain. Neuropsychobiology  16: 19 -26, 1986.  
15. Muraki,K., Nishi,Y., Okahata,H., Arai,M., Yamada,H., Fujita,S., Miyachi,Y., U eda,K., Yamawaki,S. and 
Yajima,H. : Neurotensin -like immunoreactivity (NTL1)  concentration inthe cerebrospinal fluid of 
childrenand Its alteration in a febrile aseptic meningitis. Life Sciences  40: 1365 -1370, 1987.  
16. Yamawaki,S. : Profiles of clinical effic acy and pharmacological action of zotepine. Pharnacopsychiatry  
20: 4 -7, 1987 . 
17. Kato,T. and Yamawaki,S. : A pharmacological study of veratrine -indued hyperthermia in the rat: a model 
of neuroleptic malignant syndrome. Hiroshma Journal of Medical Science  38: 173-181, 1989.  
18. Hide,I.,Kato,T. and Yamawaki,S. : In vivo determination of 5 -HT receptor -stimulated phosphoinositide 
turnover in rat brain. Journal of Neurochemistry  53: 556 -560, 1989.  
19. Yamawaki,S., Yano,E. and Uchitomi,Y. : Analysis of 497 cases of neurolep tic malignant syndrome in 
Japan. Hiroshima Journal of Anesthesia  26: 35 -44, 1990.  
20. Yamawaki,S., Kato,T. and Yano,E. : Studies on pathogenesis of neuroleptic malignant syndrome: Effect 
of dantrolene on serotonin release in rat hypothalamus. Hiroshima Journal  of Anesthesi a 26: 45 -52, 
1990.  
21. Hayakawa,H., Shimizu,M. and Yamawaki,S. : The effects of electroconvulsive shock or imipramine on 
subtypes of α1-adrenoceptors in the frontal cortex of the rat. Neuropharmacology  31: 955 -960, 1992.  
22. Shimizu,M., Nishida,A. and  Yamawaki,S.: Antidepressants inhibit spontaneous oscillations of 
intracellular  Ca2+ concentration in rat cortical cultured neurons. Neuroscience Letter s 146: 101 -104, 
1992.  
23. Nishida,A., Shimizu,M., Kanaho,Y., Nozawa,Y. and Yamawaki,S. : Characterization o f phospholipase D 
in a cell -free system of cultured cells derived from rat frontal cortex. Brain Research  595: 12 -16, 1992.  
24. Kagaya,A., Mikuni,M., Yamamoto,H., Muraoka,S., Yamawaki,S. and Takahashi,K. : Heterologous 
supersensitization between serotonin2 and  alpha2 -adrenergic receptor -mediated intracellular calcium 
mobilization in human platelets. Journal of Neural Transmission  88: 25 -36, 1992.  
25. Uchitomi,Y. and Yamawaki,S. : Chronic lithium treatment enhances the postsynaptic 5 -HT1A 
receptor -mediated 5 -HT beha vioral syndrome induced by 8 -OH-DPAT in rats via catecholaminergic 
systems. Psychopharmacology  112: 174 -179, 1993.  
26. Shimizu,M., Nishida,A. and Yamawaki,S. : Forskolin and phorbol myristate acetate inhibit intracellular 
Ca2+ mobilization induced by amitripty line and bradykinin in rat frontocortical  neurons. Journal of 
Neurochemistry  61: 1748 -1754, 1993.  
27. Shimizu,M., Nishida,A., Hayakawa,H. and Yamawaki,S. : Ca2+ release from inositol 
1,4,5 -trisphosphate -sensitive Ca2+ store by antidepressant drugs in cultured  neurons of rat frontal cortex. 
Journal of Neurochemistry  60: 595 -601, 1993.  
28. Hayakawa,H., Yokota,N., Shimizu,M., Nishida,A. and Yamawaki,S. : Repeated treatment with 
electroconvulsive shock increases numbers of serotonin1A receptors in the rat hippocampus.  Biogenic 
Amines  9: 295 -306, 1993.  
29. Motohashi,N., Okamoto,Y., Osada,M. and Yamawaki,S. : Acute swim stress increases benzodiazepine 
receptors, but not GABAA or GABAB receptors, in the rat cerebral cortex. Neurochemistry 
International  23: 327 -330, 1993.  
30. Fujikawa,T., Yamawaki,S. and Touhouda,Y.: Incidence of silent cerebral infarction in patients with major 
depression. Stroke  24: 1631 -1634, 1993.  
31. Kagaya,A., Mikuni,M., Muraoka,S., Saitoh,K., Ogawa,T., Shinno,H., Yamawaki.,S. and Takahashi,K. : 
Homologous desens itization of serotonin 5 -HT2 receptor -stimulated intracellular calcium mobilization in 
C6BU -1 glioma cells via a mechanism involving a calmodulin pathway. Journal of Neurochemistry  61: 
1050 -1056, 1993.  
32. Tanra,A.J., Kagaya,A., Motohashi,N., Uchitomi,Y. and Y amawaki,S. : TJS -010, a new prescription of 
kampo medicine with putative antidepressive and anxiolytic properties.  -A behavioral study using 
experimental models for depression and anxiety. Hiroshima Journal of Medical Sciences  43: 145 -151, 
1994.  
33. Shinno,H.,  Mikuni,M., Saitoh,K., Tomita,U., Yamawaki,S. and Takahashi,K. : Metabotropic glutamate 
receptor  in C6BU -1 glioma cell has NMDA receptor -ion channel complex -like properties and interacts 
with serotonin2 receptor -stimulated signal transduction. Journal of Neurochemistry  63: 1346 -1353, 
1994.  
34. Fukuda,H., Nishida,A., Saito,H., Shimizu,M. and Yamawaki,S. : Imipramine stimulates phospholipase 
C activity in rat brain. Neurochemistry International . 25: 567 -571, 1994.   8 
35. Nishida,A., Emoto,K., Shimizu,M., Uozumi,T. and Yamawaki,S. : Brain ischemia decreases 
phosphatidylcholine -phospholipase D but not phosphatidylinositol -phospholipase C in rats. Stroke  25: 
1247 -1251, 1994.  
36. Kawai,K., Yokota,N. and Yamawaki,S. : Effect of chronic tryptophan depletion on the circadian rhyth m 
of wheel -running activity in rats. Physiology and Behavior  55: 1005 -1013, 1994.  
37. Uchitomi,Y., Sugihara,J., Fukue,M., Kuramoto,Y., Akechi,T., Oomori,N. and Yamawaki,S. : Psychiatric 
liaison issues in cancer care in Japan. Journal of Pain and Symptom Manage ment  9: 319 -324, 
1994.  
38. Shimizu,M., Nishida,A., Fukuda,H., Saito,H. and Yamawaki,S. : Inhibitory effect of imipramine on 
depolarization -induced increases in intracellular Ca2+ of rat cortical neurons. European Journal of 
Pharmacology  268: 65 -71, 1994.  
39. Hayas hi,T., Kagaya,A., Motohashi,N. and Yamawaki,S. : Possible mechanism of dantrolene 
stabilization of cultured neuroblastoma cell plasma membranes. Journal of Neurochemistry  63: 
1849 -1854, 1994.  
40. Hayakawa,H., Shimizu,M., Nishida,A., Motohashi,N. and Yamawaki,S . : Increase in serotonin1A 
receptors in the dentate gyrus as revealed by autoradiographic analysis following repeated 
electroconvulsive shock but not imipramine treatment. Neuropsychobiology  30: 53 -56, 1994.  
41. Fujikawa,T., Yamawaki,S. and Touhouda,Y. : Back ground factors and clinical symptoms of major 
depression with silent cerebral infraction. Stroke  25: 798 -801, 1994.  
42. Okamoto,Y., Kagaya,A., Motohashi,N. and Yamawaki,S. : Inhibitory effects of lithium ion on 
intracellular Ca2+ mobilization in the rat hippoc ampal slices. Neurochemistry International  26: 
233-238, 1995.  
43. Hayashi,T., Kagaya,A., Takebayashi,M., Shimizu,M., Uchitomi,Y., Motohashi,N. and Yamawaki,S. : 
Modulation by σ ligands of intracellular free Ca2+ mobilization by N -methyl -D-aspartate in primary 
culture of rat frontal cortical neurons. The Journal of Pharmacology and Experimental 
Therapeutics  275: 207 -214, 1995.  
44. Hayakawa,H., Okamoto,Y., Shimizu,M., Nishida,A., Motohashi,N. and Yamawaki,S. : Single or 
repeated treatment with electroconvulsive shock  increases number of serotonin uptake binding sites in 
the frontal cortex. Neuropsychobiology  31: 1 -5, 1995.  
45. Hayashi,T., Nishikawa,T., Koga,K., Uchida,Y. and Yamawaki,S. : Aerophagia: a neuroleptic -associated 
tardive syndrome?  Human Psychopharmacology  10: 235-238, 1995.  
46. Takao,K., Nagatani,T., Kitamura,Y., Kawasaki,K., Hayakawa,H. and Yamawaki,S. : Chronic forced 
swim stress of rats increases frontal cortical 5 -HT2 receptors and the wet -dog shakes they mediate, 
but not frontal cortical β-adrenoceptors. Euro pean Journal of Pharmacology  294: 721 -726, 1995.  
47. Hayashi,T., Yamawaki,S., Nishikawa,T. and Jeste,D.V. : Usage and side effects of neuroleptics in 
elderly Japanese patients. American Journal of Geriatric Psychiatry  3: 308 -316, 1995.  
48. Kagaya,A., Motohashi,M.,  Kugaya,A., Yamaji,T., Hayashi,T., Okamoto,Y., Shinno,H., Takebayashi,M., 
Uchitomi,Y. and Yamawaki,S. : Cyclic GMP generation mediated by 5 -HT-2 receptors via nitric 
oxide -dependent pathway and its effects on the desensitization of 5 -HT-2 receptors in C6 g lioma cells. 
Journal of Neural Transmission  100: 27 -38, 1995.  
49. Tanra,A.J., Kagaya,A., Okamoto,Y., Muraoka,M., Motohashi,N. and Yamawaki,S. : TJS -010, a new 
prescription of oriental medicine, antagonizes tetrabenazine -induced suppression of spontaneous 
locom otor activity in rats. Progress in Neuro -Psychopharmacology & Biological Psychiatry  19: 
963-971, 1995.  
50. Shimizu,M., Nishida,A., Fukuda,H., Saito,H. and Yamawaki,S. : Enhancement of cyclic AMP 
accumulation mediated by 5 -HT after chronic amitriptyline treatme nt in NG 108 -15 cells. British 
Journal of Pharmacology  14: 1282 -1288, 1995.  
51. Kagaya,A., Mikuni,M., Okamoto,Y., Muraoka,S., Motohashi,N., Yamawaki,S. and Takahashi,K. : W -7 
facilitates 5 -HT2A receptor -mediated intracellular calcium increase in human platelet s. 
Pharmaceutical Sciences  1: 141 -143, 1995.  
52. Fujikawa,T., Yamawaki,S. and Touhouda,Y. : Silent cerebral infractions in patients with late -onset 
mania. Stroke  26: 946 -949, 1995.  
53. Kugaya,A., Kagaya,A., Uchitomi,Y., Motohashi,N. and Yamawaki,S. : Inhibition of  serotonin -induced 
Ca2+ mobilization by interleukin -1β in rat C6BU -1 glioma cells. Brain Research  682: 151 -156, 1995.  
54. Okamoto,Y., Kagaya,A., Shinno,H., Motohashi,N. and Yamawaki,S. : Serotonin -induced platelet 
calcium mobilization is enhanced in mania. Life Sciences  56: 327 -332, 1995.  
55. Uchitomi,Y., Okamura,H., Minagawa,H., Kugaya,A., Fukue,M., Kagaya,A., Oomori,N. and 
Yamawaki,S. : A survey of Japanese physicians' attitudes and practice in caring for terminally ill cancer 
patients. Psychiatry and Clinical Ne urosciences  49: 53 -57, 1995.  
56. Takebayashi,M., Motohashi,N., Saito,H., Kagaya,A. and Yamawaki,S. : Effect of acute treatment with 
sodium valproate on catecholamine and serotonin synthesis. Neuropsychobiology  32: 124 -127, 
1995.   9 
57. Okamoto,Y., Okamoto,Y., Kagaya, A., Tamiya,S., Fujita,Y., Touhouda,Y., Motohashi,N. and 
Yamawaki,S. : Serotonin -induced platelet calcium mobilization is enhanced in bulimia nervosa but not 
in anorexia nervosa. Biological Psychiatry 38: 274 -276, 1995.  
58. Saito,H., Nishida,A., Shimizu,M., Mot ohashi,N. and Yamawaki,S. : Decreased inositol 
1,4,5 -trisphosphate -specific binding in platelets from alcoholic subjects. Biological Psychiatry  40: 
886-891, 1996.  
59. Shimizu,M., Nishida,A., Fukuda,H., Saito,H. and Yamawaki,S. : Effects of chronic exposure to 
desipramine and mianserin on Ca2+ mobilization induced by noradrenaline, acetylcholine, and high K+ 
in rat frontocortical neurons. Neuropsychobiology  33: 66 -70, 1996.  
60. Saito,H., Shimizu,M., Motohashi,N. and Yamawaki,S. : Effect of chronic ethanol treatment on inositol 
1,4,5 -trisphosphate receptors and inositol 1,3,4,5 -tetrakisphosphate receptors in rat brain. 
Neuropsychobiology  33: 60 -65, 1996.  
61. Takebayashi,M., Kagaya,A., Hayashi,T., Motohashi,N. and Yamawaki,S. : γ-Aminobutyric acid 
increases intracellular Ca2+ concentration in cultured cortical neurons: Role of Cl - transport. European 
Journal of Pharmacology 297: 137 -143, 1996.  
62. Okamoto,Y., Motohashi,N., Hayakawa,H., Muraoka,M. and Yamawaki,S. : Addition of lithium  to chronic 
antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic 
receptors in the rat cerebral cortex. Neuropsychobiology 33: 17 -20, 1996.  
63. Kagaya,A., Tanra,A.J., Shinno,H., Kugaya,A., Muraoka,M., Oyamada,T. , Uchitomi,Y. and 
Yamawaki,S. : TJS -010, a new prescription of oriental medicine, enhances 8 -OH-DPAT -induced effect 
in rats. Journal of Neural Transmission  103: 69 -75, 1996.  
64. Kagaya,A., Kugaya,A., Hayashi,T., Okamoto,Y., Takebayashi,M., Uchitomi,Y. and Yama waki,S. : 
Effect of citalopram on the desensitization of serotonin -2A receptor -mediated calcium mobilization in 
rat glioma cells. Progress in Neuro -Psychopharmacology & Biological Psychiatry  20: 157 -166, 
1996.  
65. Akechi,T., Uchitomi,Y., Okamura,H., Fukue,M., Kagaya,A., Nishida,A., Oomori,N. and Yamawaki,S. : 
Usage of haloperidol for delirium in cancer patients. Supportive Care in Cancer  4: 390 -392, 1996.  
66. Yamaji,T., Kagaya,A., Uchitomi,Y., Yokota,N. and Yamawaki,S. : Effects of clomipramine and 
verapamil on 5 -HT-induced intracellular calcium changes in individual C6 rat glioma cells. 
Neuropsychobiology 33: 55 -59, 1996.  
67. Minagawa,H., Uchitomi,Y., Yamawaki,S. and Ishitani,K. : Psychiatric morbidity in terminally ill cancer 
patients. -A Prospective Study. Cancer  78: 1131 -1137, 1996.  
68. Hayashi,T., Nishikawa,T., Koga,T., Uchida,Y. and Yamawaki,S. : Prevalence of and risk factors for 
respiratory dyskinesia. Clinical Neuropharmacology  19: 390 -398, 1996.  
69. Shimizu,M., Nishida,A., Zensho,H. and Yamawaki,S. : Chronic amitriptyl ine exposure reduces 5 -HT3 
receptor -mediated cyclic GMP formation in NG 108 -15 cells. Brain  Research  741: 89 -94, 1996.  
70. Kagaya,A., Uchitomi,Y., Kugaya,A., Takebayashi,M., Nagaoka,I., Muraoka,M., Yokota,N. and 
Yamawaki,S. : Differential regulation of intrac ellular signaling systems by sodium fluoride in rat glioma 
cells. Journal of Neurochemistry 66: 1483 -1488, 1996.  
71. Fujikawa,T., Yokota,N., Muraoka,M. and Yamawaki,S. : Response of patients with major depression 
and silent cerebral infarction to antidepressan t drug therapy, with emphasis on central nervous system 
adverse reactions. Stroke  27: 2040 -2042, 1996.  
72. Yamaji,T., Kagaya,A., Uchitomi,Y., Yokota,N. and Yamawaki,S. : Effects of carbamazepine and 
sodium valproate on 5 -HT-induced calcium increase in individu al C6 rat glioma cells. 
Neuropsychobiology  34: 22 -25, 1996.  
73. Kugaya,A., Kagaya,A., Uchitomi,Y., Yokota,N. and Yamawaki,S. : Effect of interferon -αon 
DOI-induced wet -dog shakes in rats. Journal of Neural Transmission  103: 947 -955, 1996.  
74. Shimizu,M., Nishida,A., Zensho,H and Yamawaki,S. : Chronic antidepressant exposure enhances 
5-hydroxytryptamine -7 receptor -mediated cyclic adenosine monophosphate ac cumulation in rat 
frontocortical astrocytes. The Journal of Pharmacology and Experimental Therapeutics  279: 
1551 -1558, 1996.  
75. Yamawaki,S., Kagaya,A., Okamoto,Y., Shimizu,M., Nishida,A., Uchitomi,Y. : Enhanced calcium 
response to serotonin in platelets from patients with affective disorders. Journal of Psychiatry and 
Neuroscience  21: 321 -324, 1996.  
76. Kagaya,A., Uchitomi,Y., Takezaki,E., Fukue,M., Tsukano,K., Kugaya,A., Minagawa,H., Takebayashi,M., 
Zensho,H., Oyamada,T. and Yamawaki,S. : Plasma levels of cyclic GMP, immune parameters and 
depressive status during interferon therapy. Neuropsychobiology  35: 128 -131, 1997.  
77. Yamaji,T., Kagaya,A., Uchitomi,Y., Yokota,N. and Yamawaki,S. : Chronic treatment with 
antidepressants, verapamil, or lithium inhibits the serotoni n-induced intracellular calcium response in 
individual C6 rat glioma cells. Life Sciences  60: 817 -823, 1997.  
78. Hayashi,T., Nishikawa,T., Koga,I., Uchida,Y. and Yamawaki,S. : Life -threatening dysphagia following 
prolonged neuroleptic therapy. Clinical Neuroph armacology  20: 77 -81, 1997.   10 
79. Nishida,A., Saito,H., Shimizu,M., Zensho,H. and Yamawaki,S. : Phosphatidylethanol inhibits 
phosphatidylinositol -phospholipase C activity in a competitive manner with phosphatidylinositol -4, 
5-bisphosphate. Drug and Alcohol Depen dence  44: 117 -122, 1997.  
80. Nishikawa,T., Kuwahara,H., Hayashi,T., Yamawaki,S. and Tanaka,M. : Differential diagnosis of 
respiratory dyskinesia: A prevalence study using computer analysis of spirograph data. Human 
Psychopharmacology  12: 105 -110, 1997.  
81. Hayashi ,T., Nishikawa,T., Koga,I., Uchida,Y., Horiguchi,J. and Yamawaki,S. : Involvement of the α
2-adrenergic system in polydipsia in schizophrenic patients: a pilot study. Psychopharmacology  130: 
382-386, 1997.  
82. Tawara,Y., Nishikawa,T., Koga,I., Uchida,Y. and Yam awaki,S. : Transient and intermittent oral 
dyskinesia appearing in a young woman ten days after neuroleptic treatment. Clinical 
Neuropharmacology  20: 175 -178, 1997.  
83. Fujikawa,T., Yanai,I. and Yamawaki,S. : Psychosocial stressors in patients with major depre ssion and 
silent cerebral infarction. Stroke 28: 1123 -1125, 1997.  
84. Hayashi,T., Yokota,N., Takahashi,T., Tawara,Y., Nishikawa,T. Yano,T., Furutani,M., Fujikawa,T., 
Horiguchi,J. and Yamawaki,S. : Benefits of trazodone and mianserin on patients with late -life chronic 
schizophrenia and tardive dyskinesia: an add -on, double -blind, placebo -controlled study. International 
Clinical Psychopharmacology 12: 199 -205, 1997.  
85. Takao,K., Nagatani,T., Kitamura,Y. and Yamawaki,S. : Effects of corticosterone on 5 -HT1A and 5 -HT2 
receptor binding and on the receptor -mediated behavioral responses of rats. European Journal of 
Pharmacology 333: 123 -128, 1997.  
86. Shimizu,M., Nishida,A., Zensho,H., Miyata,M. and  Yamawaki,S. : Down -regulation of 
5-hydroxytryptamine7 receptors by dexametha sone in rat frontocortical astrocytes. Journal of 
Neurochemistry 68: 2604 -2609, 1997.  
87. Hayashi,T., Kagaya,A., Takebayashi,M., Oyamada,T., Inagaki,M., Tawara,Y., Yokota,N., Horiguchi,J. 
and Yamawaki,S. : Effect of dantrolene on KCI - or NMDA -inducecd intracel lular Ca2+ changes and 
spontaneous Ca2+ oscillation in cultured rat frontal cortical neurons.  Journal of Neural Transmission 
104: 811 -824, 1997.  
88. Kugaya,A., Kagaya,A., Zensho,H., Oyamada,T., Tawara,Y., Inagaki,M., Uchitomi,Y. and Yamawaki,S. : 
Modulation of  endothelin -induced intracellular Ca2+ mobilization by interleukin -1β and 
lipopolysaccharide in C6 rat glioma cells. Neuropeptides  31: 187 -192, 1997.  
89. Yanai,I., Fujikawa,T., Osada,M., Touhouda,Y. and Yamawaki,S. : Changes in auditory P300 in patients 
with m ajor depression and silent cerebral infarction. Journal of Affective Disorders  46: 263 -271, 
1997.  
90. Inami,Y., Horiguchi,J., Nishimatsu,O., Sasaki,A., Sukegawa,T., Katagiri,H. and Yamawaki,S. : A 
Polysomnographic study on periodic limb movements in patients w ith restless legs syndrome and 
neuroleptic -induced akathisia. Hiroshima Journal of Medical Sciences  46: 133 -141, 1997.  
91. Yanai,I., Fujikawa,T., Horiguchi,J., Yamawaki,S. and Touhouda,Y. : The 3 -year course and outcome of 
patients with major depression and si lent cerebral infarction. Journal of Affective Disorders  47: 
25-30, 1998.  
92. Otagaki,Y., Tohoda,Y., Osada,M., Horiguchi,J. and Yamawaki,S. : Prolonged P300 latency in eating 
disorders. Neuropsychobiology 37: 5 -9, 1998.  
93. Oyamada,T., Hayashi,T., Kagaya,A., Yokot a,N. and Yamawaki,S. : Effect of dantrolene on K+ - and 
caffeine -induced dopamine release in rat striatum assessed by in vivo microdialysis. Neurochemistry 
International  32: 171 -176, 1998.  
94. Nagaoka,I., Sasa,M. and Yamawaki,S. : 5 -HT1A receptor -mediated inhib ition of nucleus accumbens 
neurons activated by stimulation of parafascicular nucleus of thalamus. Psychopharmacology 135: 
230-235, 1998.  
95. Horiguchi,J., Yamashita,H., Yanai,I., Katagiri,H., Miyoshi,I., Yokota,N. and Yamawaki,S. :  
Effectiveness of valproate  on delirium and/or aggressive behavior in demented patients: A practical 
pilot study. International Journal of Psychiatry in Clinical Practice  2: 35 -39, 1998.  
96. Tawara,Y., Kagaya,A., Uchitomi,Y., Horiguchi,J. and Yamawaki,S. : Lipopolysaccharide regulates bo th 
serotonin -and thrombin -induced intracellular calcium mobilization in rat C6 glioma cells: possible 
involvement of nitric oxide synthase -mediated pathway. Journal of Neuroscience Research  51: 
517-525, 1998.  
97. Shimizu,M., Nishida,A., Zensho,H., Miyata,M. an d Yamawaki,S. : Agonist -induced desensitization of 
adenylyl cyclase activity mediated by 5 -hydroxytryptamine7 receptors in rat frontocortical 
astrocytes. Brain Research 784: 57 -62, 1998.  
98. Akechi,T., Kugaya,A., Okamura,H., Nishiwaki,Y., Yamawaki,S. and Uchito mi,Y. : Predictive factors for 
psychological distress in ambulatory lung cancer patients. Supportive Care in Cancer  6: 281 -286, 
1998.   11 
99. Akechi,T., Okamura,H., Yamawaki,S. and Uchitomi,Y. : Predictors of patients' mental adjustment to 
cancer: patient characte ristics and social support. British Journal of Cancer 77: 2381 -2385, 1998.  
100. Zensho,H., Nishida,A., Shimizu,M., Uchitomi,Y. and Yamawaki,S. : Heat shock protein 72 restores 
cyclic AMP accumulation after heat shock in N18TG2 cells. Brain Research  790: 278 -283, 1998.  
101. Muraoka,M., Hayakawa,H., Kagaya,A., Kojima,T. and Yamawaki,S. : Effects of carbon monoxide 
exposure on serotonergic neuronal systems in rat brain. Life Sciences  62: 2101 -2108, 1998.  
102. Uchitomi,Y., Akechi,T., Okamura,H., Kugaya,A., Zensho,H., Kagaya,A ., Saeki,T., Okamoto,Y., 
Nishida,A., Takebayashi,M. and Yamawaki,S. : Positive influence of a liaison programme on the rate of 
psychiatric consultation referrals for cancer patients. Psychiatry and Clinical Neurosciences  52: 
275-278, 1998.  
103. Hayashi,T., Furut ani,M., Taniyama,J., Kiyasu,M., Hikasa,S. Horiguchi,J. and Yamawaki,S. : 
Neuroleptic -induced meige's syndrome following akathisia: Pharmacologic characteristics. Psychiatry 
and Clinical Neurosciences 52: 445 -448, 1998.  
104. Ikeda,M., Fujikawa,T., Yanai,I., Hori guchi,J. and Yamawaki,S. : Clonazepam -induced maniacal 
reaction in a patient with bipolar disorder. International Clinical Psychopharmacology  13: 189 -190, 
1998.  
105. Takebayashi,M., Kagaya,A., Uchitomi,Y., Yokota,N., Horiguchi,J. and Yamawaki,S. :  Differential  
regulation by pregnenolone sulfate of intracellular Ca2+ increase by amino acids in primary cultured rat 
cortical neurons. Neurochemistry International 32: 205 -211, 1998.  
106. Takebayashi,M., Kagaya,A., Uchitomi,Y., Kugaya,A., Muraoka,M., Yokota,N., Horiguchi, J. and 
Yamawaki,S. : Plasma dehydroepiandrosterone sulfate in unipolar major depression. Journal of 
Neural Transmission  105: 537 -542, 1998.  
107. Akechi,T., Kugaya,A., Okamura,H., Yamawaki,S. and Uchitomi,Y. : Fatigue and its associated factors 
in ambulatory can cer patients: a preliminary study. Journal of Pain and Symptom Management 17: 
42-48, 1999.  
108. Horiguchi,J., Yamashita,H., Mizuno,S., Kuramoto,Y., Kagaya,A., Yamawaki,S. and Inami,Y. : Nocturnal 
eating/drinking syndrome and neuroleptic -induced restless legs sy ndrome.  International Clinical 
Psychopharmacology  14: 33 -36, 1999.  
109. Horiguchi,J., Shingu,T., Hayashi,T., Kagaya,A., Yamawaki,S., Horikawa,Y., Kitadai,Y., Inoue,M. and 
Nishikawa,T. : Antipsychotic -induced life -threatening 'esophageal dyskinesia'.  Internation al Clinical 
Psychopharmacology  14: 123 -127, 1999.  
110. Hosaka,T., Awazu,H., Aoki,T., Okuyama,T. and Yamawaki,S. : Screening for adjustment disorders and 
major depression in otolaryngology patients using the hospital anxiety and depression scale. 
International J ournal of Psychiatry in Clinical Practice 3: 43 -48, 1999.  
111. Inagaki,M., Kagaya,A., Takebayashi,M., Horiguchi,J. and Yamawaki,S. : Effect of acute and chronic 
administration of dehydroepiandrosterone on 
(±)-1-(2,5-dimethoxy -4-iodophenyl) -2-aminopropane -induce d wet dog shaking behavior in rats. 
Journal of Neural Transmission  106: 23 -33, 1999.  
112. Mori,K., Teramoto,K., Nagao,M., Horiguchi,J. and Yamawaki,S. : Regional cerebral blood flow in 
schizophrenia using stable xenon -enhanced computed tomography. Neuropsychobi ology  39: 
117-124, 1999.  
113. Okamoto,Y., Okamoto,Y., Kagaya,A., Horiguchi,J. and Yamawaki,S. : The relationship of the platelet 
5-HT-induced calcium response to clinical symptoms in eating disorders. Psychopharmacology 142: 
289-294, 1999.  
114. Okamoto,Y., Matsuoka, Y., Sasaki,T., Jitsuiki,H., Horiguchi,J. and Yamawaki,S. : Trazodone in the 
treatment of delirium. Journal of Clinical Psychopharmacology 19: 280 -282, 1999.  
115. Ishihara,K., Amano,T., Hayakawa,H., Yamawaki,S. and Sasa,M. : Enhancement of serotonin1A 
receptor f unction following repeated electroconvulsive shock in young rat hippocampal neurons in vitro. 
International Journal of Neuropsychopharmacology 2: 101 -104, 1999.  
116. Hayashi,T., Su,T. -P., Kagaya,A., Nishida,A., Shimizu,M. and Yamawaki,S. : Neuroleptics with 
differential affinities at dopamine D2 receptors and sigma receptors affect differently the 
N-methyl -D-aspartate -induced increase in intracellular calcium concentration: Involvement of protein 
kinase. SYNAPSE  31: 20 -28, 1999.  
117. Takebayashi,M., Fujikawa,T., Kaga ya,A., Horiguchi,J. and Yamawaki,S. : Lithium and clonazepam 
treatment of two cases with cluster headache.  Psychiatry and Clinical Neurosciences  53: 535 -537, 
1999.  
118. Akechi,T., Kugaya,A., Okamura,H., Nakano,T., Okuyama,T., Mikami,I., Shima,Y., Yamawaki,S. an d 
Uchitomi,Y. : Suicidal thoughts in cancer patients: clinical experience in psycho -oncology. Psychiatry 
and Clinical Neurosciences  53: 569 -573, 1999.  
119. Mikami,I., Akechi,T., Kugaya,A., Okuyama,T., Nakano,T., Okamura,H., Yamawaki,S. and Uchitomi,Y. : 
Screeni ng for nicotine dependence among smoking -related cancer patients. Japanese Journal of 
Cancer Research 90: 1071 -1075, 1999.   12 
120. Yamashita,H., Horiguchi,J., Mizuno,S., Kuramoto,Y., Yamawaki,S. and Inami,Y. : A case of 
neuroleptic -induced unilateral akathisia wit h periodic limb movements during sleep in the opposite side. 
Psychiatry and Clinical Neurosciences  53: 291 -293, 1999.  
121. Sato,M., Nakane,N., Hayashida,M., Koshino,Y., Uchimura,H., Tsutsumi,T., Koyama,T., Kusumi,I., 
Akiyama,K., Saito,H., Saijo,T., Ito,C., Kubo ta,Y., Nishikawa,T., Kuroda,Y., Hamamura,T., Fujiwara,Y., 
Higuchi,T. and Yamawaki,S. : Algorithm for the treatment of schizophrenia in Japan. International 
Journal of Psychiatry in Clinical Practice 3: 271 -276, 1999.  
122. Higuchi,T., Fujiwara,Y., Iida,M., Iwana mi,A., Kanba,S., Kitamura,H., Motohashi,N., Oshima,A., Shioe,K., 
Uchitomi,Y., Yamada,K., Yamawaki,S., Yokota,N. and Sato,M. :  Algorithm for the treatment of mood 
disorders in Japan. International Journal of Psychiatry in Clinical Practice 3: 277 -285, 1999 . 
123. Kagaya,A., Okada,A., Tawara,Y., Inagaki,M., Jitsuiki,H., Kozuru,T., Miyoshi,I., Katagiri,H., Uchitomi,Y., 
Horiguchi,J., Nakata,Y. and Yamawaki,S. : Lithium chloride inhibits thrombin -induced intracellular 
calcium mobilization in C6 rat glioma cells. Neur o-Psychopharmacology & Biological Psychiatry 
24: 85 -95, 2000.  
124. Jitsuiki,H., Kagaya,A., Goto,S., Horiguchi,J. and Yamawaki,S. : Effect of lithium carbonate on the 
enhancement of serotonin 2A receptor elicited by dexamethasone. Neuropsychobiology 41: 55 -61, 
2000. 
125. Kozuru,T., Kagaya,A., Takebayashi,M., Horiguchi,J. and Yamawaki,S. : Chronic electroconvulsive 
shock decreases ( ±)1-(4-iodo-2,5-dimethoxyphenyl) -2-aminopropane hydrochloride (DOI) -induced 
wet-dog shake behaviors of dexamethasone -treated rats. Life Sci ence  66: 1271 -1279, 2000.  
126. Nishida,A., Zensho,H., Hisaoka,K., Miyata,M. and Yamawaki,S. : Differential display of ethanol -induced 
gene in N18TG2 cells. Alcohol Clinical Experimental Research 24: 348 -351, 2000.  
127. Kagaya,A., Okada,A., Jitsuiki,H., Tawara,Y., In agaki,M., Takebayashi,M., Saeki,T., Nishida,A., 
Nakata,Y. and Yamawaki,S. : Effect of heat stress on serotonin -2A receptor -mediated intracellular 
calcium mobilization in rat C6 glioma cells. Journal of Neural Transmission 107: 919 -929, 2000.  
128. Akechi,T., Oka mura,H., Kugaya,A., Nakano,T., Nakanishi,T., Akizuki,N., Yamawaki,S. and 
Uchitomi,Y. : Suicidal ideation in cancer patients with major depression.  Japan Journal of Clinical 
Oncology 30: 221 -224, 2000.  
129. Suenaga,T., Tawara,Y., Goto,S., Kouhata,S., Kagaya,A., Horiguchi,J., Yamanaka,Y. and 
Yamawaki,S. : Risperidone treatment of neuroleptic -induced tardive extrapyramidal symptoms. 
International Journal of Psychiatry in Clinical Practice  4: 241 -243, 2000.  
130. Akechi,T., Saeki,M., Kugaya,A., Okamura,H., Nishiwaki,Y., Y amawaki,S. and Uchitomi,Y. : 
Psychometric properties of the Japanese version of the mental adjustment to cancer (MAC) scale. 
Psycho -Oncology  9: 395 -401, 2000.  
131. Takebayashi,M., Kagaya,A., Inagaki,M., Kozuru,T., Jitsuiki,H., Kurata,K., Okamoto,Y. and 
Yamawaki ,S. : Effects of antidepressants on γ-aminobutyric acid - and N -methyl -D-aspartate -induced 
intracellular Ca2+ concentration increases in primary cultured rat cortical neurons. 
Neuropsychobiology 42: 120 -126, 2000.  
132. Uchitomi,Y., Kugaya,A., Akechi,T., Nakano,T., Wenner,M., Okamura,H., Takebayash i,M., Kagaya,A., 
Saeki,T. and Yamawaki,S. : Three sets of diagnostic criteria for major depression and correlations with 
serotonin -induced platelet calcium mobilization in cancer patients. Psychopharmacology  153: 
244-248, 2001.  
133. Kagaya,A., Kugaya,A., Takeba yashi,M., Fukue -Saeki,M., Saeki,T., Yamawaki,S. and Uchitomi,Y. : 
Plasma concentrations of interleukin -1β, interleukin -6, soluble interleukin -2 receptor and tumor 
necrosis factor -α of depressed patients in Japan.  Neuropsychobiology  43: 59 -62, 2001.  
134. Akechi,T., Okamura,H., Yamawaki,S. and Uchitomi,Y. : Why do some cancer patients with depression 
desire an earl y death and others do not? Psychosomatics 42: 141 -145, 2001.  
135. Kurata,K., Takebayashi,M., Kagaya,A., Morinobu,S. and Yamawaki,S. : Effect of β-estradiol on 
voltage -gated Ca2+ channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone. 
Euro pean Journal of Pharmacology  416: 203 -212, 2001.  
136. Akechi,T., Okuyama,T., Imoto,S., Yamawaki,S. and Uchitomi,Y. : Biomedical and psychosocial 
determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients. Breast 
Cancer Research and Treatment 65: 195 -202, 2001.  
137. Kouhata,S., Kagaya,A., Nakae,S., Nakata,Y. and Yamawaki,S. : Effect of acute lipopolysaccharide 
administration on ( ±)-1-(2,5-dimethoxy -4-iodophenyl) -2  aminopropane -induced wet dog shake 
behavior in rats: comparison with bo dy weight change and locomotor activity. Progress in 
Neuro -Psychopharmacology & Biological Psychiatry  25: 395 -407, 2001.  
138. Katagiri,H., Kagaya,A., Nakae,S., Morinobu,S. and Yamawaki,S. : Modulation of serotonin -2A receptor 
function in rats after repeated tre atment with dexamethasone and L -type calcium channel antagonist 
nimodipine. Progress in Neuro -Psychopharmacology & Biological Psychiatry  25: 1269 -1281, 
2001.   13 
139. Sasaki,Y., Hayakawa,H., Kagaya,A., Horiguchi,J. and Yamawaki,S. : Effect of forced running stress on 
behavior and on brain serotonin system in rats. Biogenic Amines  16: 137 -155, 2001.  
140. Fujimaki,K., Morinobu,S., Takahashi,J., Yamawaki,S., Kato,N., Kannno,M., Okuyama,N., Kawakatsu,S., 
Otani,K., Kusumi,I. and Koyama,T. : Nucleotide sequene analysis of the binding site on the inositol 
1,4,5 -trisphosphate type -1 receptor in bipolar disorder - a negative study. Journal of Affective 
Disorders 65: 139 -143, 2001.  
141. Takahashi,J., Tanaka,K., Morinobu,S., Li,Sheng -Tian., Kato,K., Ohkawa,M., Yamawaki,S. and 
Kato,N. : I nfluence of restraint stress on the expression and the serine/threonine phoshatase activity of 
calcineurin in the rat brain. SYNAPSE 40: 130 -136, 2001.  
142. Fukumoto,T., Morinobu,S., Okamoto,Y., Kagaya,A. and Yamawaki,S. : Chronic lithium treatment 
increases th e expression of brain -derived neurotrophic factor in the rat brain. Psychopharmacology 
158: 100 -106, 2001.  
143. Miyoshi,I., Kagaya,A., Kohchi,C., Morinobu,S. and Yamawaki,S.: Characterization of 5 -HT2A receptor 
desensitization and the effect of cycloheximide on  it in C6 cells. Journal of Neural Transmission  108: 
249-260, 2001.  
144. Yamashita,H., Fujikawa,T., Yanai,I., Morinobu,S. and Yamawaki,S. : Clinical features and treatment 
response of patients with major depression and silent cerebral infarction. Neuropsychobio logy 44: 
176-182, 2001.  
145. Hisaoka,K., Nishida,A., Koda,T., Miyata,M., Zensho,H., Morinobu,S., Ohta,M. and Yamawaki,S. : 
Antidepressant drug treatments induce glial cell line -derived neurotrophic factor(GDNF) synthesis and 
release in rat C6 glioblastoma cells . Journal of Neurochemistry 79: 25 -34, 2001.  
146. Kagaya,A., Katagiri,H., Tawara,Y., Kugaya,A., Inagaki,M., Miyoshi,I., Jitsuiki,H., Kozuru,T., Kouhata,S., 
Morinobu,S. and Yamawaki,S. : Effect of sub -chronic treatment with duloxetine on serotonin -2A 
receptor fu nction in vivo and in vitro. Biogenic Amines  16: 541 -554, 2001.  
147. Matsuoka Y, Miyake Y, Arakaki H, Tanaka K, Saeki T, Yamawaki S.  Clinical utility and validation of the 
Japanese version of Memorial Delirium Assessment Scale in a psychogeriatric inpatient set ting. 
General Hospital Psychiatry  23:36-40, 2001 . 
148. Yamashita,H., Fujikawa,T., Yanai,I., Morinobu,S. and Yamawaki,S. : Cognitive dysfunction in 
recovered depressive patients with silent cerebral infarction. Neuropsychobiology  45: 12 -18, 2002.  
149. Tamura,T., Mori nobu,S., Okamoto,Y., Kagaya,A. and Yamawaki,S. : The effects of antidepressant 
drug treatments on activator protein -1 binding activity in the rat brain. Progress in 
Neuro -Psychopharmacology & Biological Psychiatry  26: 375 -381, 2002.  
150. Mori,K., Yamashita,H., Nagao,M., Horiguchi,J. and Yamawaki,S. : Effects of anticholinergic drug 
withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic 
patients. Pharmacopsychiatry 35: 6 -11, 2002.  
151. Yamashita,H., Morinobu,S., Yamawaki,S. , Horiguchi,J. and Nagao,M. : Effect of risperidone on sleep in 
schizophrenia: a comparison with haloperidol. Psychiatry Research 109: 137 -142, 2002.  
152. Saeki,T., Asukai,N., Miyake,Y., Miguchi,M. and Yamawaki,S. : Characteristics of family functioning in 
patients with endogenous monopolar depression. Hiroshima Journal of Medical Sciences  51: 55 -62, 
2002.  
153. Tsuji,S., Kikkawa,S., Horiguchi,J., Yamashita,H., Kagaya,A., Morinobu,S. and Yamawaki,S. : Meige 
syndrome with apraxia of lid opening after the discontinuatio n of sulpiride treatment. 
Pharmacopsychiatry  35: 155 -156, 2002.  
154. Tanaka,K., Takahashi,J., Morinobu,S., Fujimaki,K., Tsuji,S., Kato,K., Ohkawa,M., Yamawaki,S. and 
Kato,N. : Imipramine, but not lithium, induces the serine/threonine phosphatase activity of cal cineurin 
without affecting its mRNA expression in the rat brain. Psychopharmacology 162: 339 -344, 2002.  
155. Asahi,S., Nishikawa,T., Kurata,K., Morinobu,S. and Yamawaki,S. : A case of myclonus, resembling 
epileptic seizure, induced by short -term sulpiride treat ment.  International Journal of Psychiatry in 
Clinical Practice  6: 215 -216, 2002.  
156. Uchitomi,Y., Kugaya,A., Akechi,T., Nakano,T., Inagaki,M., Matsuoka,Y., Kagaya,A. and Yamawaki,S. : 
Lack of association between suicidal ideation and enhanced platelet 5 -HT2A r eceptor -Mediated 
calcium mobilization in cancer patients with depression. Biological Psychiatry 52: 1159 -1165, 2002.  
157. Nishida,A., Hisaoka,K., Zensho,H., Uchitomi,Y., Morinobu,S. and Yamawaki,S. : Antidepressant drugs 
and cytokines in mood disorders. Interna tional Immunopharmacology  2: 1619 -1626, 2002.  
158. Matsuoka Y, Nakano T, Inagaki M, Sugawara Y, Akechi T, Imoto S, Murakami K, Yamawaki S, 
Uchitomi Y.Cancer -related intrusive thoughts as an indicator of poor psychological adjustment at 3 or 
more years after bre ast surgery: a preliminary study.  
Breast Cancer Research and Treatment 76:117 -124, 2002 . 
159. Okada,G., Okamoto,Y., Morinobu,S., Yamawaki,S. and Yokota,N. : Attenuated left prefrontal activation 
during a verbal fluency task in patients with depression. Neuropsy chobiology 47: 21 -26, 2003.   14 
160. Inoue,S., Saeki,T., Mantani,T., Okamura,H. and Yamawaki,S. : Factors related to patient's mental 
adjustment to breast cancer: patient characteristics and family functioning. Supportive Care in 
Cancer 11: 178 -184, 2003.  
161. Ueda,K., Okamoto,Y., Okada,G., Yamashita,H., Hori,T. and Yamawaki,S. : Brain activity during 
expectancy of emotional stimuli: an fMRI study.  Neuroreport 14: 51 -55, 2003.  
162. Tsuji,S., Morinobu,S., Tanaka,K., Kawano,K. and Yamawaki,S. : Lithium, but not valproate, induc es the 
serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its 
expression. Journal of Neural Transmission 110:413 -425 2003 . 
163. Katagiri,H., Kagaya,A., Kozuru,T., Jitsuiki,H., Kawano,K., Morinobu,S. and Yamawaki, S. : Effect of 
repeated treatment with lamotrigine on locomotor activity and on DOI -elicited wet dog shakes in rats. 
Biogenic Amines  17: 149 -159, 2003.  
164. Matsuoka,Y., Yamawaki,S., Inagaki,M., Akechi,T. and Uchitomi,Y. : A volumetric study of amygdala in 
canc er survivors with intrusive recollections. Biological Psychiatry  54: 736 -743, 2003.  
165. Morinobu,S., Fujimaki,K., Kawano,K., Tanaka,K., Takahashi,J., Ohkawa,M., Yamawaki,S. and 
Kato,N. : Influence of immobilization on stress on the expression and phosphatase a ctivity of protein 
phosphatase 2A in the rat brain. Biological Psychiatry  54: 1060 -1066, 2003.  
166. Kagaya,A., Okamura,H., Takebayashi,M., Akechi,T., Morinobu,S., Yamawaki,S. and Uchitomi,Y. : 
Mood disturbance and neurosteroids in women with breast cancer. Stress and Health  19: 227 -231, 
2003.  
167. Shirao,N., Okamoto,Y., Okada,G., Okamoto,Y. and Yamawaki,S. : Temporomesial activation in young 
females assosiated with unpleasant words concerning body image. Neuropsychobiology  48: 136 -142, 
2003.  
168. Fujikawa,T., Takahashi,T. , Kinoshita,A., Kajiyama,H., Kurata,A., Yamashita,H. and Yamawaki,S. : 
Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of 
Alzheimer type. Neuropsychobiolog y 49: 201 -204, 2004.  
169. Hisaoka,K., Nishida,A., Takebaya shi,M., Koda,T., Yamawaki,S. and Nakata,Y. : Serotonin increases 
glial cell line -derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Research  1002: 
167-170, 2004 . 
170. Asahi,S., Okamoro,Y., Okada,G., Yamawaki,S. and Yokota,N. : Negative corr elation between right 
prefrontal activity during response inhibition and impulsiveness: A fMRI study. European Archives of 
Psychiatry and Clinical Neuroscience  254: 245 -251, 2004.  
171. Suenaga,T., Morinobu,S., Kawano,K., Sawada,T. and Yamawaki,S. : Influence of  immobilization stress 
on the levels of CaMKII and phospho -CaMKII in the rat hippocampus. International Journal of 
Neuropsychopharmacology  7: 299 -309, 2004.  
172. Mori,K., Nagao,M., Yamashita,H., Morinobu,S. and Yamawaki,S. : Effect of switching to atypical 
antipsychotics on memory in patients with chronic schizophrenia. Progress in 
Neuro -Psychopharmacology & Biological Psychiatry  28: 659 -665, 2004.  
173. Kurata,K., Takebayashi,M., Morinobu,S. and Yamawaki,S. : β-estradiol, dehydroepiandrosterone, and 
dehydroepiandrost erone sulfate protect against N -Methyl -D-aspartate -induced neurotoxicity in rat 
hippocampal neurons by different mechanisms. The Journal of Pharmacology and Experimental 
Therapeutics . 311: 237 -245, 2004.  
174. Yamashita,H., Mori,K., Nagao,M., Okamoto,Y., Morinob u,S. and Yamawaki,S. : Effects of changing 
from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in 
a Japanese population. The Journal of Clinical Psychiatry  65: 1525 -1530, 2004.  
175. Morinobu,S., Kawano,K. and Yamawaki,S. : Lithium and protein phosphatases: apoptosis or 
neurogenesis? Clinical Neuroscience Research  4: 263 -269, 2004.  
176. Kusaka,K., Morinobu,S., Kawano,K. and Yamawaki,S. : Effect of neonatal isolation on the 
noradrenergic transduction system in the rat  hippocampal slice. Synapse  54: 223 -232, 2004.  
177. Tanaka,SC., Doya,K., Okada,G., Ueda,K., Okamoto,Y. and Yamawaki,S. : Prediction of immediate and 
future rewards differentially recruits cortico -basal ganglia loops. Nature Neuroscience  7: 887 -893, 
2004.  
178. Sawada ,T., Morinobu,S., Tsuji,S., Kawano,K., Watanabe,T., Suenaga,T., Takahashi,T., Yamawaki,S. 
and Nishida,A. : Reduction in levels of amphiphysin 1 mRNA in the hippocampus of aged rats 
subjected to repeated variable stress. Neuroscience  126: 461 -466, 2004.  
179. Toki,S., Morinobu,S., Yoshino,A. and Yamawaki,S. : A case of venous thromboembolism probably 
associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics. The 
Journal of Clinical Psychiatry  65: 1576 -1577, 2004.  
180. Shirao,N., Okam oto,Y., Mantani,T., Okamoto,Y. and Yamawaki,S. : Gender differences in brain activity 
generated by unpleasant word stimuli concerning body image: an fMRI study. The British Jornal of 
Psychiatry 186: 48-53, 2005.  
181. Akizuki,N., Yamawaki,S., Akechi,T., Nakano,T . and Uchitomi,Y. : Development of an impact 
thermometer for use in combination with the distress thermometer as a brief screening tool for  15 
adjustment disorders and/or major depression in cancer patients. Journal of Pain and Symptom 
Management  29: 91 -99, 2 005. 
182. Shirao,N., Okamoto,Y., Okada,G., Ueda,K. and Yamawaki,S. : Gender differences in brain activity 
toward unpleasant linguistic stimuli concerning interpersonal relationships: an fMRI study. European 
Archives of Psychiatry and Clinical Neuroscience  255: 327-333, 2005.  
183. Yamashita,H., Okamoto,Y., Morinobu,S., Yamawaki,S. and Kahkonen,S. : Visual emotional stimuli 
modulation of auditory sensory gating studied by magnetic P50 suppression. Eur Arch Psychiatry 
Clinical Neurosci.  255: 99 -103, 2005.  
184. Mantani,T., Ok amoto,Y., Shirao,N., Okada,G. and Yamawaki,S. : Reduced activation of posterior 
cingulate cortex during imagery in subjects with high degrees of alexithymia: a  functional magnetic 
resonance imaging  study. Biological Psychiatry 57: 982 -990, 2005.  
185. Ozono,S., Saeki,T., Inoue,S., Mantani,T., Okamura,H. and Yamawaki,S. : Family functioning and 
psychological distress among Japanese breast cancer patients and families. Supportive Care in 
Cancer  13: 1044 -1050, 2005 . 
186. Okamura,M., Yamawaki,S., Akechi,T., Taniguchi,K. a nd Uchitomi,Y. : Psychiatric disorders following 
first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. 
Japanese Journal of Clinical Oncology  35: 302 -309, 2005.  
187. Yamashita,H., Mori,K., Nagao,M., Okamoto,Y., Morin obu,S. and Yamawaki,S. : Influence of aging on 
the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with 
schizophrenia.  American Journal of Geriatric Psychiatry 13: 377 -384, 2005.  
188. Kobayakawa,M., Yamawaki,M., Hamazaki,K., Akechi,T., Inagaki,M. and Uchitomi,Y. : Levels of 
omega -3 fatty acid in serum phospholipids and depression in patients with lung cancer. British 
Journal of Cancer  93:1329 -1333, 2005 . 
189. Takebayashi,M., Hisaoka,K., Nishida,A., Tsuchioka,M., Miyoshi,I., Kozuru, T., Hikasa,S., Okamoto,Y., 
Shinno,H., Morinobu,S. and Yamawaki,S. : Decreased levels of whole blood glial cell line -derived 
neurotorophic factor (GDNF) in remitted patients with mood disorders. International Journal of 
Neuropsychopharmacology  9: 607-612, 2006. 
190. Kurosaki,M., Shirao,N., Yamashita,H., Okamoto,Y. and Yamawaki,S. : Distored images of one's own 
body activates the prefrontal cortex and limbic/paralimbic system in young women: a functional 
magnetic resonance imaging study. Biological Psychiatry  59: 380-386, 2006.  
191. Imanaka,A., Morinobu,S., Toki,S. and Yamawaki,S. : Importance of early environment in the 
development of post -traumatic stress disorder -like behaviors.  Behavioural Brain Research  173: 
129-137, 2006.  
192. Erabi,K., Morinobu,S., Kawano,K., Tsuji,S and Yamawaki,S. : Neonatal isolation changes the 
expression of IGF -IR and IGFBP -2 in the hippocampus in response to adulthood restraint stress. The 
International Journal of Neuropsychopharmacology , 19: 1 -13, 2006.  
193. Takahashi,T., Morinobu,S., Iwamoto,Y. and Yamawaki,S. : Effect of paroxetine on enhanced 
contextual fear induced by single prolonged stress in rats.  Psychopharmacology , 189: 165 -173, 
2006.  
194. Onoda,K., Okamoto,Y., Shishida,K., Hashizume,A., Ueda,K., Kinoshita,A., and Yamashita,H., 
Yamawaki,S. : Antic ipation of affective image modulates visual evoked magnetic fields(VEF). 
Experimantal Brain Research , 175: 536 -543, 2006.  
195. Tanaka,SC., Samejima,K., Okada,G., Ueda,K., Okamoto,Y., Yamawaki,S. and Doya,K. : Brain 
mechanism of reward prediction under predictab le and unpredictable environmental dynamics. Neural 
Networks , 19: 1233 -1241, 2006.  
196. Schweighofer,N., Shishida,K., Han,CE., Okamoto,Y., Tanaka,SC., Yamawaki,S. and Doya,K. : 
Humans can adopt optimal discounting strategy under real -time constraints. PLoS Comp utational 
Biology , 10: e152 , 2006.  
197. Shishida,K., Hashizume,A., Onoda,K., Okamoto,Y. and Yamawaki,S. : Enhanced reactivity and 
delayed recovery of sensorimoter cortex in the novelty seeking personality. Neuropsychobiology , 54: 
215-225, 2006 . 
198. Ozono,S., Saeki, T., Mantani,T., Ogata,A., Okamura,H. and Yamawaki,S. : Factors related to 
posttraumatic stress in adolescent survivors of childhood cancer and their parents. Support Care 
Canc er, 15: 309 -317, 2007.  
199. Toki,S., Morinobu,S., Imanaka,A., Yamamoto,S., Yamawaki,S.  and Honma,K. : Importance of early 
lighting conditions in maternal care by dam as well as anxiety and memory later in life of offspring. 
European Journal of Neuroscience , 25: 815 -829, 2007.  
200. Hama,S., Yamashita,H., Shigenobu,M. Watanabe,A., Kurisu,K. Yamawa ki,S., and Kitaoka,T. : 
Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal 
ganglia. European Archives of Psychiatry and Clinical Neuroscience , 257:149 -152, 2007 . 
201. Hisaoka,K., Takebayashi,M., Tuchioka,M.,  Maeda,N., Nakata,Y. and Yamawaki,S. : Antidepressnts 
increase glial cell line -derived neurotrophic factor production through monoamine independent  16 
activation of protein tyrosine kinase and extracellular signal -regulated kinase in glial cells. Journal of 
Pharmacology and Experimental Therapeutics , 321: 148 -157, 2007 . 
202. Mantani,T., Saeki,T., Inoue,S., Okamura,H., Daino,M., Kataoka,T. and Yamawaki,S. : Factors related 
to anxiety and depression  in women with breast cancer and their husbands: role of alexithymia and 
family functioning. Support Care Cancer , 15:859 -868, 2007 . 
203. Takami,H., Okamoto,Y., Yamashita,H., Okada,G. and Yamawaki,S. : Attenuated anterior cingulate 
activation during a verbal fluency task in elderly patients with a history of multiple -episode depr ession. 
American Journal of Geriatric Psychiatry , 15:594 -603, 2007 . 
204. Iwamoto,Y., Morinobu,S., Takahashi,T. and Yamawaki,S. : Single prolonged stress increases 
contextual freezing and the expression of glycine transporter 1 and vesicle -associated membrane 
protein 2 mRNA in the hippocampus of rats. Progress in Neuro -Psychopharmacology & Biological 
Psychiatry , 31:642 -651, 2007 . 
205. Onoda,K., Okamoto,Y., Shishida,K., Hashizume,A., Ueda,K., Yamashita,H., Yamawaki,S. : Anticipation 
of affective images and event -relate d desynchronization (ERD) of alpha activity: an MEG study. Brain 
Research  1151: 134 -141, 2007.  
206. Hama,S., Yamashita,H., Shigenobu,M., Watanabe,A., Hiramoto,K., Kurisu,K., Yamawaki,S., 
Kitaoka,T. : Depression or apathy and functional recovery after stroke. International Journal of 
Geriatric Psychiatry  22: 1046 -1051, 2007 . 
207. Mantani,T., Saeki,T., Inoue,S., Okamura,H., Daino,M., Kataoka,T., Yamawaki,S. : Factors related to 
anxiety and depression  in women with breast cancer and their husbands: role of alexithymia a nd family 
functioning. Support Care Cancer  15: 859 -868, 2007.  
208. Hama,S., Yamashita,H., Shigenobu,M., Watanabe,A., Hiramoto,K., Takimoto,Y., Arakawa,R., 
Kurisu,K., Yamawaki,S., Kitaoka,T. : Sitting balance as an early predictor of functional inprovement in 
association with depressive symptoms in stroke patients. Psychiatry and Clinical Neurosci ences  61: 
543-551, 2007.  
209. Tanaka,SC., Schweighofer,N., Asahi,S., Shishida,K., Okamoto,Y., Yamawaki,S., Doya,K. : Serotonin 
differentially regulates short - and long -term p rediction of rewards in the ventral and dorsal striatum. 
PLoS ONE  2: e1333, 2007.  
210. Imanaka,A., Morinobu,S., Toki,S., Yamamoto,S., Matsuki,A., Kozuru,T., Yamawaki,S. : Neonatal tactile 
stimulation reverses the effect of neonatal isolation on open -field and a nxiety -like behavior, and pain 
sensitivity in male and female adult Sprague -Dawley rats. Behavioural Brain Research  186: 91 -97, 
2008.  
211. Kawano,K., Morinobu,S., Sawada,T., Tsuji,S., Erabi,K., Fuchikami,M., Kozuru,T., Yamawaki,S., 
Hisaoka,K., Takebayashi,M. : Prior neonatal isolation reduces induction of NGF mRNA and decreases 
GDNF mRNA in the hippocampus of juvenile and adult rodents subjected to immobilization stress. 
Synapse  62: 259 -267, 2008.  
212. Onoda,K., Okamoto,Y., Toki,S., Ueda,K., Shishida,K., Kinoshita,A. , Yoshimura,S., Yamashita,H., 
Yamawaki,S. : Anterior cingulated cortex modulates preparatory activation during certain anticipation of 
negative picture. Neuropsychologia  46: 102 -110, 2008.  
213. Yonezawa,H., Otagaki,Y., Miyake,Y., Okamoto,Y., Yamawaki,S. : No di fferences are seen in the 
regional cerebral blood flow in the restricting type of anorexia nervosa compared with the binge 
eating/purging type. Psychiatry and Clinical Neurosciences  62: 26 -33, 2008.  
214. Yamamoto,S., Morinobu,S., Fuchikami, M., Kurata,A., Kozuru ,T., Yamawaki,S. : Effects of single 
prolonged stress and D -cycloserine on contextual fear extinction and hippocampal NMDA receptor 
expression in a rat model of PTSD. Neuropsychopharmacology , 33: 2108 -2116, 2008.  
215. Mantani,A., Fujikawa,T., Ohmori,N., Yamawak i,S. : Methylphenidate in the treatment of geriatric 
patients with vascular depression: a retrospective chart review. American Journal of Geriatric 
Psychiatry  16: 336 -337, 2008.  
216. Schweighofer,N., Bertin,M., Shishida,K., Okamoto,Y., Tanaka,SC., Yamawaki,S., Doya,K. : 
Low-serotonin levels increase delayed reward discounting in humans. Journal of Neuroscience  28: 
4528 -4532, 2008.  
217. Tanaka,K., Morinobu,S., Ichimura,M., Asakawa,A., Inui,A., Hosoda,H., Kangawa,K., Yamawaki,S. : 
Decreased levels of ghrelin, cortisol,  and fasting blood sugar, but not n -octanoylated ghrelin, in 
Japanese schizophrenic inpatients treated with olanzapine. Progress in 
Neuro -Psychopharmacology & Biological Psychiatry  32: 1527 -1532 , 2008.  
218. Hama,S., Yamashita,H., Kato,T., Shigenobu,M., Watanabe ,A., Sawa,M., Kurisu,K., Yamawaki,S., 
Kitaoka,T. : ‘Insistence on recovery’ as a positive prognostic factor in Japanese stroke patients. 
Psychiatry and Clinical Neurosciences  62: 386 -395, 2008 . 
219. Fuchikami,M., Morinobu,S., Kurata,A., Yamamoto,S. Yamawaki,S. : Single immobilization stress 
differentially alters the expression profile of transcripts of the brain -derived neurotrophic factor (BDNF) 
gene and histone acetylation at its promoters in the rat hippocampus. International Journal of 
Neuropsychopharmacolog y 12: 73 -82, 2009.   17 
220. Yoshimura,S., Ueda,K., Suzuki,SI., Onoda,K., Okamoto,Y., Yamawaki,S. : Self -referential processing 
of negative stimuli within the ventral anterior cingulate gyrus and right amygdala. Brain and Cognition , 
69: 218 -225, 2009.  
221. Okada,G., Okam oto,Y., Yamashita,H., Ueda,K., Takami,H., Yamawaki,S. : Attenuated prefrontal 
activation during a verbal fluency task in remitted major depression. Psychiatry and Clinical 
Neurosciences  63: 423 -425, 2009.  
222. Kurata,A., Morinobu,S., Fuchikami,M., Yamamoto,S., Yamawaki,S. : Maternal postpartum learned 
helplessness (LH) affects maternal care by dams and responses to the LH test in adolescent offspring. 
Hormones and Behavior  56: 112 -120, 2009.  
223. Onoda,K., Okamoto,Y., Yamawaki,S. : Neural correlates of associative me mory: the effects of negative 
emotion. Neuroscience Research  64: 50 -55, 2009.  
224. Miyake,Y., Okamoto,Y., Onoda,K., Shirao,N., Mantani,T., Yamawaki,S. : Neural correlates of 
alexithymia in response to emotional stimuli: a study of anorexia nervosa patients. Hiroshima Journal 
of Medical Sciences  58: 1 -8, 2009.  
225. Onoda K, Okamoto Y, Nakashima K, Nittono H, Ura M, Yamawaki S. Decreased  ventral anterior 
cingulate cortex activity is associated with reduced social pain  during emotional support. Social 
Neurosci ences . 4:443-54. 2009.  
226. Tanaka SC, Shishida K, Schweighofer N, Okamoto Y, Yamawaki S, Doya K. : Serotonin affects 
association of aversive outcomes to past actions. Journal of  Neurosci ence .29:15669 -74, 2009 
227. Ozono S, Saeki T, Mantani T, Ogata A, Okamura H, Nakagawa SI, Ueda K, Inada H,  Yamawaki S. 
Psychological distress related to patterns of family functioning  among Japanese childhood cancer 
survivors and their parents. Psychooncology . 2010 (in press)  
228. Yoshimura, S., Okamoto, Y., Onoda, K., Matsunaga, M., Ueda, K., Suzuk i, S., Yamawaki, S.,: Rostral 
anterior cingulated  cortex activity mediates the relationship between the depressive symptoms and the 
medial prefrontal cortex activity. Journal of Affective Disorders  122:76 -85, 2010. 
229. Yoshino A, Okamoto Y, Onoda K, Yoshimura S, Kunisato Y, Demoto Y, Okada G,  Yamawaki 
S.:Sadness enhances the experience of pain via neural activation in the anterior cingulate cortex and 
amygdala. Neuroimage  50:1194 -1201, 2010.  
230. Miyake Y, Okamoto Y, Onoda K, Shirao N, Okamoto Y, Otagaki Y, Yamawaki  S.:Neural processing of 
negative word stimuli concerning body image in patients with  eating disorders: An fMRI study. 
Neuroimage . 50:1333 -1339  2010 . 
231. Matsunaga M, Okamoto Y, Suzuki SI, Kinoshita A, Yoshimura S, Yoshino A, Kunisato Y, Yamawaki 
S.:Psychosoci al functioning in patients with treatment -resistant depression after group cognitive 
behavioral therapy. BMC Psychiatry  10: 2010 (e-pub) 
232. Kunisato,Y., Okamoto,Y., Okada,G., Aoyama,S., Demoto,Y., Munakata,A., Nomura,M., Onoda,K., 
Yamawaki,S. : Modulation of default -mode network activity by acute tryptophan depletion is associated 
with mood change: A resting state functional magnetic resonance imaging study. Neuroscience 
Research  69: 129 -134, 2011.  
233. Takei,S., Morinobu,S., Yamamoto,S., Fuchikami,M., Matsumoto,T. , Yamawaki,S. : Enhanced 
hippocampal BDNF/TrkB signaling in response to fear conditioning an animal model of posttraumatic 
stress disorder.  Journal of Psychiatric Research  45: 460 -468, 2011.  
234. Kunisato,Y., Okamoto,Y., Okada,G., Aoyama,S., Nishiyama,Y., Onoda ,K., Yamawaki,S. : Personlity 
traits and the amplitude of spontaneous low -frequency oscillations during resting state.  Neuroscience 
Letters  492: 109 -113, 2011.  
235. Hama,S., Yamashita,H., Yamawaki,S., Kurisu,K. : Post -stroke depression and apathy: Interactions 
between functional recovery, lesion location, and emotional response. Psychogeriatrics  11: 68 -76,  
236. Onoda,K., Okamoto,Y., Kunisato,Y., Aoyama,S., Shishida,K., Okada,G., Tanaka,SC., Schiweighoer,N., 
Yamaguchi,S., Doya,K., Yamawaki,S. : Inter individual disco unt factor differences in reward prediction 
are topographically associated with caudate activation. Experimental Brain Research  212: 593 -601, 
2011.  
237. Fujita,Y., Takebayashi,M., Hisaoka,K., Tsuchioka,M., Morinobu,S., Yamawaki,S. : Asymmetric 
alternation of th e hemodynamic response at the prefrontal cortex in patients with schizophrenia during 
electroconvulsive therapy: a near -infrared spectroscopy study. Brain Research  1410: 132 -140, 2011.  
238. Sumiyoshi,H., Mantani,A., Nishiyama,S., Fujiwaki,S., Ohta,S., Masuda,Y. , Tomita,Y., Tarumoto,N., 
Yamawaki,S. : Yokukansan treatment in chronic renal failure patients with dementia receiving 
hemodialysis: an open label study. American Journal of Geriatric Psychiatry  19: 906 -907, 2011.  
239. Fuchikami,M., Morinobu,S., Segawa,M., Okam oto,Y., Yamawaki,S., Ozaki,N., Inoue,T., Kusumi,I., 
Koyama,T., Tsuchiyama,K., Terao,T. : DNA methylation profiles of the brain -derived neurotrophic 
factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One  6: e23881, 
2011(e -pub).    18 
240. Okada,G., Okamoto,Y., Kunisato,Y., Aoyama,S., Nishiyama,Y., Yoshimura,S., Onoda,K., Toki,S., 
Yamashita,H., Yamawaki,S. : The effect of negative and positive emotionality on associative memory: 
an FMRI study. PLoS One 6: e24862, 2011 (e-pub). 
241. Kobayakawa,M., I nagaki,M., Fujimori,M., Hamazaki,K., Hamazaki,T., Akechi,T., Tsugane,S., 
Nishiwaki,Y., Goto,K., Hahsimoto,K., Yamawaki,S., Uchitomi,Y. : Serum brain -derived neurotrophic 
factor and antidepressant -naïve  major depression after lung cancer diagnosis. Japanese  Journal of 
Clinical Oncology  41: 1233 -1237, 2011.  
242. Yamawaki,Y., Fuchikami,M., Morinobu,S., Segawa,M., Matsumoto,T., Yamawaki,S. : 
Antidepressant -like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action 
in the rat hippocampus. The World Journal of Biological Psychiatry  2011 (e-pub). 
243. Demoto,Y., Okada,G., Okamoto,Y., Kunisato,Y., Aoyama,S., Onoda,K., Munakata,A., Nomura,M., 
Tanaka,SC., Schweighofer,N., Doya,K., Yamawaki,S. : Neural and personality correlates of individual 
difference s related to the effects of acute tryptphan depletion on future reward evaluation. 
Neuropsychobiology  65: 55 -64, 2012.  
244. Segawa,M., Morinobu,S., Matsumoto,T., Fuchikami,M., Yamawaki,S. : Electro convulsive seizure, but 
not imipramine, rapidly up -regulates pr o-BDNF and t -PA, leading to mature BDNF production, in the rat 
hippocampus. The International Journal of Neuropsychopharmacology  6: 1-12, 2012.  
245. Fujita,Y., Morinobu,S., Takei,S., Fuchikami,M., Matsumoto,T., Yamamoto,S., Yamawaki,S. : Vorinostat, 
a histone d eacetylase inhibitor, facilitates fear extinction and enhances expression of the hippocampal 
NR2B -containing NMDA receptor gene. Journal of Psychiatric Research  46: 635 -643, 2012.  
246. Miyake,Y., Okamoto,Y., Onoda,K., Shirao,N., Okamoto,Y., Yamawaki,S. : Brain activation during the 
perception of stressful word stimuli concerning interpersonal relationships in anorexia nervosa patients 
with high degress of alexithymia in an fMRI paradigm. Psychiatry Research  201: 113 -119, 2012.  
247. Sawa,M., Yamashita,H., Fujimaki,K.,  Okada,G., Takahashi,T., Yamawaki,S. : Depressive symptoms 
and apathy are associated with psychomotor slowness and frontal activation. European Archives of 
Psychiatry and Clinical Neuroscience , 262: 493 -499, 2012.  
248. Fujimaki,K., Morinobu,S., Yamashita,H., Ta kahashi,T., Yamawaki,S. : Predictors of quality of life in 
inpatients with schizophrenia. Psychiatry Research , 197: 199 -205, 2012.  
249. Yoshino,A., Okamoto,Y., Onoda,K., Shishida,K., Yoshimura,S., Kunisato,Y., Demoto,Y., Okada,G., 
Toki,S., Yamashita,H., Yamawak i,S. : Sadness enhances the experience of pain and affects 
pain-evoked cortical activities: an MEG study. The Journal of Pain  13: 628 -635, 2012  
250. Kunisato,Y., Okamoto,Y., Ueda,K., Onoda,K., Okada,G., Yoshimura,S., Suzuki,S., Samejima,K., 
Yamawaki,S. : Effect s of depression on reward -based decision making and variability of action in 
probabilistic learning. Journal of Behavior Therapy and Experimental Psychiatry  43: 1088 -1094, 
2012  
251. Yamawaki,S., Okada,G., Okamoto,Y., Liverzon,I.: Mood dysregulation and stabiliz ation: perspectives 
from emotional cognitive neuroscience. The International Journal of Neuropsychopharmacology  
15: 681 -694, 2012.  
252. Kinoshitha,A., Okamoto,Y., Okada,G., Demoto,Y., Kunisato,Y., Yoshimura,S., Onoda,K., Kamachi,M., 
Yamawaki,S.: Sex differences  in neural activation to amviguous facial expression in happy and sad 
context. Percept Mot Skills  115: 349 -359, 2012.  
253. Sato,G., Yoshimura,S., Yamashita,H., Okamoto,Y., Yamawaki,S. : The neurocognitive effects of 
aripiprazole compared with risperidone in the  treatment of schizophrenia. Hiroshima Journal of 
Medical Sciences  61: 75 -83, 2012.  
254. Murakami,T., Hama,S., Yamashita,H., Onoda,K., Kobayashi,M., Kanazawa,J., Yamawaki,S., Kurisu,K.: 
Neuroanatomic pathways associated with poststroke affective and apathetic d epression. The 
American Journal of Geriatric Psychiatry  21: 840 -847, 2013.  
255. Segawa,M., Morinobu,S., Matsumoto,T., Fuchikami,M., Yamawaki,S. : Electro convulsive seizure, but 
not imipramine, rapidly up -regulates pro -BDNF and t -PA, leading to mature BDNF prod uction, in the rat 
hippocampus. The International Journal of Neuropsychopharmacology  16: 339 -350, 2013.  
256. Sawa,M., Yamashita,H., Fujimaki,K., Okada,G., Takahashi,T., Yamawaki,S. : Negative correlation 
between affective symptoms and prefrontal activation duri ng a verbal fluency task: a near -infrared 
spectroscopy study. Neuropsychobiology  67: 103 -110, 2013  
257. Machino,A., Jitsuiki,H., Okamoto,Y., Izumitani,S., Kimura,Y., Suzuki,K., Tanaka,T., Inoue,T., 
Koyama,T., Wada,K., Masaoka,Y., Sasaki,T., Yoshimura,R., Nakamu ra,J., Sumitani,S., Ohmori,T., 
Yamawaki,S. : The valproate serum level in maintenance therapy for bipolar disorder in Japan. 
Hiroshima Journal of Medical Sciences  62: 7 -12, 2013.  
258. Yoshimura,S., Okamoto,Y., Onoda,K., Matsunaga,M., Okada,G., Kunisato,Y., Yosh ino,A., Ueda,K., 
Suzuki,SI., Yamawaki,S. : Cognitive behavioral therapy for depression changes medical prefrontal and 
ventral anterior cingulated  cortex activity associated with self -refrerental processing. Social Cognitive 
and Affective Neuroscience  2013( e-Pub).   19 
259. Matsumoto,Y., Morinobu,S., Yamamoto,S., Matsumoto,T., Takei,S., Fujita,Y., Yamawaki,S. : Vorinostat 
ameliorates impaired fear extinction possibly via the hippocampal NMDA -CaMKII pathway in an animal 
model of posttraumatic stress disorder. Psychopha rmacology  229: 51 -62, 2013.  
260. Sumiyoshi,H., Mantani,A., Nishiyama,S., Fujiwaki,S., Ohta,S., Masuda,Y., Tomita,Y., Tarumoto,N., 
Yamawaki,S. : Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with 
behavioral and psychological symp toms of dementia: an open -label study. American Journal of 
Geriatric Psychiatry  21: 1082 -1085, 2013.  
261. Yoshino,A., Okamoto,Y., Onoda,K., Kinoshita,A., Shishida,K., Machino,A., Fukumoto,T., Yamashita,H., 
Yoshida,H., Yamawaki,S. : Distinctive neuroal responses  to pain stimuli during induced sadness in 
patients with somatoform pain disorder: an fMRI study. Neuroimage Clinical  12: 782 -789, 2013.  
262. Toki,S., Okamoto,Y., Onoda,K., Kinoshita,A., Shishida,K., Machino,A., Fukumoto,T., Yamashita,H., 
Yoshida,H., Yamawaki,S . : Automatic and intentional brain responses during evaluation of face 
approachability: correlations with trait anxiety. Neuropsychobiology  68: 156 -167, 2013.  
263. Nakao,T., Matsumoto,T., Shimizu,D., Morita,M., Yoshimura,S., Northoff,G., Morinobu,S., Okamoto,Y ., 
Yamawaki,S. : Resting state low -frequency fluctuations in prefrontal cortex reflect degrees of harm 
avoidance and novelty seeking: an exploratory NIRS study. Frontiers in Systems Neuroscience  7: 
115, 2013(eCollection).  
264. Nakao,T., Matsumoto,T., Morita,M.,  Shimizu,D., Yoshimura,S., Northoff,G., Morinobu,S., Okamoto,Y., 
Yamawaki,S. : The degree of early life stress predicts decreased medial prefrontal activations and the 
shift from internally to externally guided decision making: An exploratory NIRS study du ring resting 
state and self -oriented task. Frontiers in Human Neuroscience  7: 339, 2013(eCollection).  
265. Yoshimura,Y., Okamoto,Y., Onoda,K., Okada,G., Toki,S., Yoshino,A., Yamashita,H., Yamawaki,S. : 
Psychosocial functioning is correlated with activation int the anterior cingulate cortex and left lateral 
prefrontal cortex during a verbal fluency task in euthymic bipolar disorder: a preliminary fMRI study. 
Psychiatry and Clinical Neurosciences  68: 188 -196, 2014.  
266. Yoshimura,S., Okamoto,Y., Yoshino,A., Kobayakawa, M., Machino,A., Yamawaki,S. : Neural basis of 
anticipatory  anxiety reappraisals. PLoS ONE  9: e102836, 2014(eCollection).  
267. Murakami,T., Hama,S., Yamashita,H., Onoda,K., Hibino,S., Sato,H., Ogasa,S., Yamawaki,S., 
Kurisu,K. : Neuroanatomic pathway associated with attentional deficits after stroke. Brain Research  
28: 25 -32, 2014.  
268. Yoshimura,S., Okamoto,Y., Onoda,K., Matsunaga,M., Okada,G., Kunisato,Y., Yoshino,A., Ueda,K., 
Suzuki,S., Yamawaki,S. : Cognitive behavioral therapy for depression changes medical prefr ontal and 
ventral anterior cingulate cortex activity associated with self -referential processing. Social Cognitive 
and Affective Neuroscience  9: 487 -493, 2014.  
269. Toki,S., Okamoto,Y., Onoda,K., Matsumoto,T., Yoshimura,S., Kunisato,Y. Okada,G., Shishida,K., 
Kobayakawa,M., Fukumoto,T., Machino,A., Inagaki,M., Yamawaki,S. : Hippocampal activation during 
associative encoding of word pairs its relation to symptomatic improvement  in depression: a functional 
and volumetric MRI study. Journal of Affective Disorders  152-154: 462 -467, 2014.  
270. Hayashi,A., Okamoto,Y., Yoshimura,S., Yoshino,A., Toki,S., Yamashita,H., Matsuda,F., Yamawaki,S. : 
Visual imagery while reading concrete and abstract Japanese kanji words: an fMRI study. 
Neuroscience Research  79: 61 -66, 2014.  
271. Yoshino, A., Okamoto,Y., Kunisato,Y., Yoshimura,S., Jinnin R., Hayashi,Y., Kobayakawa,M., Doi,M., 
Oshita,K., Nakamura,R., Tanaka,K., Yamashita,H., Kawamoto,M., Yamawaki,S. : Distinctive 
spontaneous regional neural activity in patients with somatoform pain disorder:  a preliminary 
resting -state fMRI study.  Psychiatry Research: Neuroimaging  221: 246 -248, 2014.  
272. Okada,S. Morinobu,S., Fuchikami,M., Segawa,M., Yokomaku,K., Kataoka,T., Okamoto,Y., 
Yamawaki,S. : The potential of SLC6A4 gene methylation analysis for the diagn osis and treatment of 
major depression. Journal of Psychiatric Research  53: 47 -53, 2014.  
273. Hiramatsu,T., Nakanishi,K., Yoshimura,S., Yoshino,A., Adachi,N., Okamoto,Y., Yamawaki,S., Ochi,M. : 
The dorsolateral prefrontal network is involved in pain perception in knee osteoarthritis patients. 
Neuroscience Letters  581: 109 -114, 2014.  
274. Machino,A., Kunisato,Y., Matsumoto,T., Yoshimura,S., Ueda,K., Yamawaki,Y., Okada,G., Okamoto,Y., 
Yamawaki,S. : Possible involvement of rumination in gray matter abnormalities in pers istent symptoms 
of major depression: An exploratory magnetic resonance imaging voxel -based morphometry study. 
Journal of Affective Disorders  168: 229 -235, 2014.  
275. Takagaki,K., Okamoto,Y., Jinnin,R., Mori,A., Nishiyama,Y., Yamamura,T., Takebayashi,Y., Ogata,A ., 
Okamoto,Y., Miyake,Y., Shimoda,H., Kawakami,N., Yamawaki,S. : Behavioral characteristics of 
subthreshold depression. Journal of Affective Disorders  168: 472 -475, 2014.  
276. Zohar,J., Nutt,DJ., Kupfer,DJ., Moller,HJ., Yamawaki,S., Spedding,M., Stahl,SM. : A p roposal for an 
updated neuropsychopharmacological nomenclature. European Neuropsychopharmacology  24: 
1005 -1014 , 2014 .  20 
277. Toki,S., Hashimoto,E., Masuda,M., Machino,A., Yamawaki,S. : A case of chronic anorexia nervosa 
with child -bearning by in vitro fertilizati on necessitating comprehensive team support. Journal of the 
Royal Society of Medicine Open  5: 2054270441560039, 2014(eCollection).  
278. Shibasaki,C., Takebayashi,M., Fujita,Y., Yamawaki,S. : Factors associated with the risk of relapse in 
schizophrenic patients after a response to  electroconvulsive therapy: a retrospective study. 
Neuropsychiatric Disease and Treatment  11: 67 -73, 2015.  
279. Fuchikami,M., Yamamoto,S., Morinobu,S., Okada,S., Yamawaki,Y., Yamawaki,S. : The potential use 
of histone deacetylase inhibitors in the treatment of depression. Progress in 
Neuro -Psychopharmacology and Biological Psychiatry , 2016 Jan 4;64:320 -4. doi: 
10.1016/j.pnpbp.2015.03.010. Epub 2015 Mar 25.  
280. Shimizu Y, Yoshimoto J, Toki S, Takamura M, Yoshimura S, Okamoto Y, Yamawaki S, Doya 
K.:Toward  Probabilistic Diagnosis and Understanding of Depression Based on Functional MRI Data 
Analysis with Logistic Group LASSO.  PLoS One.  2015 May 1;10(5):e0123524. doi: 
10.1371/journal.pone.0123524. eCollection 2015.  
281. Nishiyama Y, Okamoto Y, Kunisato Y, O kada G, Yoshimura S, Kanai Y, Yamamura T, Yoshino A, 
Jinnin R, Takagaki K, Onoda K, Yamawaki S. : fMRI Study of Social Anxiety during Social Ostracism 
with and without Emotional Support.  PLoS One.  2015 May 22;10(5):e0127426. doi: 
10.1371/journal.pone.012742 6. eCollection 2015.  
282. Mizui T, Ishikawa Y, Kumanogoh H, Lume M, Matsumoto T, Hara T, Yamawaki S, Takahashi M, 
Shiosaka S, Itami C, Uegaki K, Saarma M, Kojima M. : BDNF pro -peptide  actions facilitate 
hippocampal  LTD and are altered by the common BDNF polymorp hism Val66Met.  Proc Natl Acad 
Sci U S A.  2015 Jun 9;112(23):E3067 -74. doi: 10.1073/pnas.1422336112. Epub 2015 May 26.  
283. Yoshino A, Okamoto Y, Doi M, Horikoshi M, Oshita K, Nakamura R, Otsuru N, Yoshimura S, Tanaka 
K, Takagaki K, Jinnin R, Yamashita H, Kawamo to M, Yamawaki S.:  Effectiveness of group cognitive 
behavioral therapy for somatoform pain disorder patients in Japan: A preliminary non -case -control 
study.  Psychiatry Clin Neurosci. 2015 Dec;69(12):763 -72. doi: 10.1111/pcn.12330. Epub 2015 Aug 
5. 
284. Tsukue R , Okamoto Y, Yoshino A, Kunisato Y, Takagaki K, Takebayashi Y, Tanaka K, Konuma K, 
Tsukue I, Yamawaki S.:  Do Individuals with Alcohol Dependence Show Higher Unfairness Sensitivity? 
The Relationship Between Impulsivity and Unfairness Sensitivity in Alcohol -Dependent Adults. Alcohol 
Clin Exp Res.  2015 Oct;39(10):2016 -21. doi: 10.1111/acer.12832. Epub 2015 Sep 1.  
285. Mori A, Okamoto Y, Okada G, Takagaki K, Jinnin R, Takamura M, Kobayakawa M, Yamawaki S.: 
Behavioral activation can normalize neural hypoactivation in  subthreshold depression during a 
monetary incentive delay task.  J Affect Disord.  2016 Jan 1;189:254 -62. doi: 
10.1016/j.jad.2015.09.036. Epub 2015 Oct 3.  
286. Hayashi Y, Okamoto Y, Takagaki K, Okada G, Toki S, Inoue T, Tanabe H, Kobayakawa M, Yamawaki 
S.: Direc t and indirect influences of childhood abuse on depression symptoms in patients with major 
depressive disorder.  BMC Psychiatry. 2015 Oct 14;15:244. doi: 10.1186/s12888 -015-0636 -1.PMID: 
26467656 Free PMC Article  
287. Kaichi Y, Okada G, Takamura M, Toki S, Akiyam a Y, Higaki T, Matsubara Y, Okamoto Y, Yamawaki S, 
Awai K.:  Changes in the regional cerebral blood flow detected by arterial spin labeling after 6 -week 
escitalopram treatment for major depressive disorder.  J Affect Disord.  2016 Apr;194:135 -43. doi: 
10.1016 /j.jad.2015.12.062. Epub 2016 Jan 21.  
288. Shibasaki C, Takebayashi M, Itagaki K, Abe H, Kajitani N, Okada -Tsuchioka M, Yamawaki S.:     
Altered serum levels of matrix metalloproteinase -2, -9 in response to electroconvulsive therapy for 
mood disorders.  Int J Neuropsychopharmacol.  2016 Sep;19(9). pii: pyw019. doi: 
10.1093/ijnp/pyw019.  
289. Yamamura T, Okamoto Y, Okada G, Takaishi Y, Takamura M , Mantani A, Kurata A, Otagaki Y, 
Yamashita H, Yamawaki S:  Association of thalamic hyperactivity with treatment -resistant depression 
and poor response in early treatment for major depression: a resting -state fMRI study using fractional 
amplitude of low -frequency fluctuations.  Transl Psychiatry.  2016 Mar 8;6:e754. doi: 
10.1038/tp.2016.18.  
290. Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, 
Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawa ki S.: 
Behavioral activation for late adolescents with subthreshold depression: a randomized controlled trial.  
Eur Child Adolesc Psychiatry . 2016 Mar 22.  
291 Uchida H, Yamawaki S, Bahk WM, Jon DI: Neuroscience -based Nomenclature (NbN) for Clinical 
Psychoph armacology and Neuroscience. Clin Psychopharmacol Neurosci. 2016 May 31;14(2):115 -6. 
doi: 10.9758/cpn.2016.14.2.115.   21 
292  Hama S, Murakami T, Yamashita H, Onoda K, Yamawaki S, Kurisu K.: Neuroanatomic pathways 
associated with monoaminergic dysregulation af ter stroke.  Int J Geriatr Psychiatry. 2016 Jun 1. doi: 
10.1002/gps.4503.  
293  Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, 
Okamoto Y, Miyake Y, Ogata A, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S.: Mechanisms  
of behavioral activation for late adolescents: Positive reinforcement mediate the relationship between 
activation and depressive symptoms from pre -treatment to post -treatment.   
J Affect Disord. 2016 Nov 1;204:70 -3. doi: 10.1016/j.jad.2016.06.046. Epub 201 6 Jun 15.   
294 Itagaki K, Takebayashi M, Shibasaki C, Kajitani N, Abe H, Okada -Tsuchioka M, Yamawaki S.:  Factors 
associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar 
depression.  J Affect Disord.  2017 Jan 15;208:1 13-119. doi: 10.1016/j.jad.2016.08.047. Epub 2016 
Oct 11.  
295 Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, 
Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S.:  
Behavioral acti vation for late adolescents with subthreshold depression: a randomized controlled trial.  
Eur Child Adolesc Psychiatry. 2016 Nov;25(11):1171 -1182. Epub 2016 Mar 22.  
296 Yoshimura S, Okamoto Y, Matsunaga M, Onoda K, Okada G, Kunisato Y, Yoshino A, Ueda K, Su zuki 
SI, Yamawaki S.:  Cognitive behavioral therapy changes functional connectivity between medial 
prefrontal and anterior cingulate cortices.  J Affect Disord.  2017 Jan 15;208:610 -614. doi: 
10.1016/j.jad.2016.10.017. Epub 2016 Oct 19.  
297 Mori A, Okamoto Y,  Okada G, Takagaki K, Jinnin R, Takamura M, Kobayakawa M, Yamawaki S.:  
 Corrigendum to "Behavioral activation can normalize neural hypoactivation in subthreshold depression 
during a monetary incentive delay task"  J Affect Disord. 2017 Jan 15;208:670. doi: 
10.1016/j.jad.2015.12.023. Epub 2015 Dec 19.  
298 Suhara T, Chaki S, Kimura H, Furusawa M, Matsumoto M, Ogura H, Negishi T, Saijo T, Higuchi M, 
Omura T, Watanabe R, Miyoshi S, Nakatani N, Yamamoto N, Liou SY, Takado Y, Maeda J, Okamoto 
Y, Okubo Y, Yamada M,  Ito H, Walton NM, Yamawaki S.: Strategies for Utilizing Neuroimaging 
Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.  Int J 
Neuropsychopharmacol.  2017 Apr 1;20(4):285 -294. doi: 10.1093/ijnp/pyw111.  
299 Takamura M, Okamoto Y, Okada G, Toki S, Yamamoto T, Yamamoto O, Jitsuiki H, Yokota N, Tamura 
T, Kurata A, Kaichi Y, Akiyama Y, Awai K, Yamawaki S.: Disrupted Brain Activation and Deactivation 
Pattern during Semantic Verbal Fluency Task in Patients with Major Depression.  
Neuro psychobiology.  2016;74(2):69 -77. doi: 10.1159/000453399. Epub 2017 Jan 5.  
300 Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, 
Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S.:  Detailed cours e of 
depressive symptoms and risk for developing depression in late adolescents with subthreshold 
depression: a cohort study.  Neuropsychiatr Dis Treat.  2016 Dec 22;13:25 -33. doi: 
10.2147/NDT.S117846. eCollection 2017.  
301  Yamamoto T, Toki S, Siegle GJ, Ta kamura M, Takaishi Y, Yoshimura S, Okada G, Matsumoto T, 
Nakao T, Muranaka H, Kaseda Y, Murakami T, Okamoto Y, Yamawaki S. ：Increased amygdala 
reactivity following early life stress: a potential resilience enhancer role.  BMC Psychiatry.  2017 Jan 
18;17(1):27. doi: 10.1186/s12888 -017-1201 -x. 
 
- Review Articles  
 
<Japanese Journals>    more than 2 60 
 
<English Journals>  
 
1. Yamawak i,S., Kagaya,A., Tawara,Y. and Inagaki,M. : Intracellular calcium mechanism in the 
pathophysiology of affective disorders. Life Sciences  62: 1665 -1670, 1998.  
2. Nishida,A., Zensho,H., Hisaoka,K., Okamoto,Y., Uchitomi,Y. and Yamawaki,S. : Molecular 
mechanis ms of alcoholism in the nervous system. Recent Research Develpment of Neurochemistry  
2: 139 -155, 1999.  
3. Yamawaki,S.: The use and development of anxiolytics in Japan. European 
Neuropsychopharmacology  9: S413 -S419, 1999.  
4. Yamawaki,S. : Psychopharmacology  of serotonin in mood disorders. Singapore Medical Journal  41: 
5-9, 2000.   22 
5. Nakae,S., Kagaya,A., Katagiri,H., Jitsuiki,H., Fukumoto,T., Tamura,T., Kouhata,S., Morinobu,S., 
Sasa,M., Yamawaki,S. : Serotonin -2A receptor and the receptor -mediated signaling sy stems in rats: 
possible implication for pathophysiology of mood disorders. Current Topics in Neurochemistry  3: 
83-95, 2002.  
5. Nishida,A., Hisaoka,K., Morinobu,S. and Yamwaki,S. : Genetic research of mood disorders. Current 
Topics in Neurochemistry  3: 116 -121, 2002 . 
6. Nishida,A., Hisaoka,K., Zensho,H., Uchitomi,Y., Morinobu,S., Yamawaki,S. : Antidepressant drugs and 
cytokines in mood disorders. International Immunopharmacology  2: 1619 -1626, 2002.  
7. Morinobu,S. and Yamawaki,S. Mood stabilizers and protein phosphata ses: apoptosis or neurogenesis? 
Clinical Neuroscience Research  4: 263 -269, 2004.  
8. Yamamoto S, Morinobu S, Takei S, Fuchikami M, Matsuki A, Yamawaki S, Liberzon I. Single 
prolonged stress: toward an animal model of posttraumatic stress  disord er. Depress Anxi ety. 
26:1110 -7, 2009  
9. Fuchikami,M., Yamamoto,S., Morinobu,S., Takei,S., Yamawaki,S. : Epigecetic regulation of BDNF 
gene in response to stress.  Psychiatry Investigation  7: 251 -256, 2010.  
10. Yamawaki,S., Okada,G., Okamoto,Y., Liberzon,I. : Mood dysregulation an d stabilization : Perspectives 
from emotional cognitive neuroscience.  International Journal of Neuropsychopharmacology  17: 
1-14, 2011.  
11. Yamamoto,S., Morinobu,S., Fujita,Y., Yamawaki,S. : Histone acetylation in the hippocampus and fear 
extinction. Biological Psychiatry  72: 2 -3, 2012.  
12.   Hasan ,A., Falkai ,P., Wobrock ,T., Lieberman ,J., Glenthoj ,B., Gattaz ,W.F., Thibaut ,F., Möller ,H.J., 
Yamawaki,S., et al. : World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for 
Biological Treatment of Schizop hrenia, part 1: update 2012 on the acute treatment of schizophrenia 
and the management of treatment resistance.  World J Biol Psychiatry ;13:318-378,2012  
13.   Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, Thibaut F, Möller HJ; WFSBP 
Task  Force on Treatment Guidelines for Schizophrenia ：World Federation of Societies of Biological 
Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 
Management of special circumstances: Depression, Suicidality, substanc e use disorders and 
pregnancy and lactation.  World J Biol Psychiatry. 2015 Apr;16(3):142 -70. doi : 
10.3109/15622975.2015.1009163  
14.  Zohar J, Stahl S, Moller HJ, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin GM, Nutt 
D: A review of the curre nt nomenclature for psychotropic agents and an introduction to the 
Neuroscience -based Nomenclature Eur Neuropsychopharmacol.  2015 Dec;25(12):2318 -25. doi: 
10.1016/j.euroneuro.2015.08.019. Epub 2015 Sep 7.  
 
 
 
 
- Book Chapters  
 
<Japanese Books>    81 
 
<Engli sh Books>  
 
1. Yamawaki,S., Kagaya,A., Hayakawa,H., Okamoto,Y., Kugaya,A., Takebayashi,M., Muraoka,M. and 
Uchitomi,Y. : Pathophysiology of affective disorders: Serotonin receptor function and intracellular 
calcium signaling. In: Serotonin in the Central Nervou s System and Periphery  (Eds. Takada,A. and 
Curzon,G.) Elsevier Science, Amsterdam, 31 -39, 1995.  
2. Yamawaki,S. and Hayashi,T. : Intracellular calcium mechanism in the pathogenesis of neuroleptic 
malignant syndrome. In.: Malignant Hyperthermia  (Eds. Morio,M., Kikuchi,H. and Yuge,O.) 
Springer -Verlag, Tokyo, 187 -195, 1996.  
3. Yamawaki,S., Kagaya,A., Okamoto,Y., Uchitomi,Y., Shimizu,M. and Nishida,A. :  Role of intracellular 
calcium mechanisms in the pathophysiology of affective disorders. In : Preclinical and Clinic al 
Strategies for the Treatment of Neurodegenerative, Cerebrovascular and Mental Disorders (Ed. 
Shibuya,T.) Karger, Basel, 106 -115, 1996.  
4. Ishihara,K., Amano,T., Nagaoka,I., Matsubayashi,H., Yamawaki,S. and Sasa,M. : 7 -OH-DPAT(D3 
agonist) -induced inhibition  of neuronal activities in nucleus accumbens in vivo. In: Preclinical and 
Clinical Strategies for the Treatment of Neurodegenerative, Cerebrovascular and Mental 
Disorders  (Ed. Shibuya, T.) Karger, Basel, 151 -155, 1996.  
5. Yamawaki,S., Hayashi,T., Nagaoka,I., Saito,H., Yokota,N. and Uchitomi,Y. : Cultural aspect of tardive 
dyskinesia. In: Neuroleptic -Induced Movement Disorders (Eds. Yassa,R. Nair,V. and Jeste,D. V.) 
Cambridge University Press, New York, 259 -266, 1997.   23 
6. Yamawaki,S. and Hayashi,T. : Neuroleptic ma lignant syndrome. In : Current Psychiatric Therapy II 
(Ed. Dunner,D.L.) W.B.Sanders Company, New York, 206 -210, 1997.  
7. Kagaya,A. and Yamawaki,S. : Immunological aspects of mood disorders : Interaction between cytokine 
and intracellular calcium signaling. In  : Signal Transduction in Affective Disorders (Eds. Ozawa,H., 
Saito,T. and Takahata,N.) Springer -Verlag, Tokyo, 35 -47, 1997.  
8. Uchitomi,Y. and Yamawaki,S. : Truth -telling practice in cancer care in Japan. In : Annals New York 
Academy of Sciences  809: 290 -299, 1997.  
9. Yamawaki,S. and Kagaya,A. : Intracellular calcium signaling systems in the pathophysiology of affective 
disorders. In : Calcium Ion Modulators: The New Wave of Psychotropic Drugs  (Eds. Inoue,K. and 
Watanabe,Y.) Gordon and Breach Science Publishers,  London, 135 -145, 1998.  
10. Yamawaki,S. : Depression: a major psychological and emotional problem. In: Current Perspectives 
and Future Directions in Palliative Medicine (Eds. Eguchi,K., Klastersky,J. and Feld,R.) 
Springer -Verlag, Tokyo, 93 -94, 1998.  
11. Okamura,H. , Akechi,T., Kugaya,A., Mikami,I., Okumura,T., Nakano,T., Kagaya,A., Yamawaki,S. and 
Uchitomi,Y. : Depression in patients with advanced cancer. In: Current Perspectives and Future 
Directions in Palliative Medicine (Eds. Eguchi,K., Klastersky,J. and Feld,R. ) Springer -Verlag, Tokyo, 
67-76, 1998.  
12. Saeki,T., Mantani,Y., Yamawaki,S. and Uchitomi,Y. : The role of Japanese families in cancer care. In: 
Cancer and the Family (Eds. Baider,L., Cooper,C. and Kaplan,A.) John Wiley & Sons, New York, 
111-117, 2000.  
13. Yamawak i,S., Kagaya,A., Okamoto,Y., Takebayashi,M. and Saeki,T. : Effects of antidepressants and 
lithium on intracellular calcium signaling. In: Contemporary Neuropsychiatry (Eds. Miyoshi,K., 
Shapiro,C.M., Gaviria,M. and Morita,Y.) Springer -Verlag, Tokyo, 257 -262, 2001.  
14. Saeki,T., Mantani,T., Inoue,S. and Yamawaki,S. : Effects of family functioning on psychological 
well-being of cancer patients. In: Contemporary Neuropsychiatry  (Eds. Miyoshi,K., Shapiro,C.M., 
Gaviria,M. and Morita,Y.) Springer -Verlag, Tokyo, 460 -464, 2001.  
15. Morinobu,S., Yamawaki,S., Fukumoto,T., Tsuji,S., Suenaga,T., Takahashi,J., Tanaka,K. and 
Fujimaki,K. : Lithium and signal transduction. In: Catecholamine Research: From Molecular Insights 
to Clinical Medicine . (Eds. Nagatsu,T., et al.) Kluwer Acad emic Plenum Publishers, New York, 
435-437, 2002.  
16. Fujikawa,T. and Yamawaki,S.: Latent brain infarction and mood disorder. In: Recent Advances in the 
Research of Affective Disorder in Japan  (Eds. Okuma,T., Kanba,S. and Inoue,Y.) Elsevier Science, 
Tokyo, 131 -137, 2002.  
17. Morinobu,S., Tsuji,S., Takahashi,M., Russell,DS., Takahashi,J., Tanaka,K., Fujimaki,K., Yamawaki,S., 
Endoh,S., and Endoh,M. : Stress vulnerability induced by neonatal isolation and the disturbance 
between the phosphorylation and dephosphorylatio n of CREB. In: PTSD -Brain Mechanisms and 
Clinical Implications -. (Eds. Kato,N., Kawata,M., Pitman,RK.) Springer, Tokyo, 37 -46, 2005.  